2. člen MKUNSŠ

Konvencija se v izvirniku v angleškem jeziku in prevodu v slovenskem jeziku glasi: The General Conference of the United Nations Educational, Scientific and Cultural Organization, hereinafter referred to as “UNESCO”, meeting in Paris, from 3 to 21 October 2005, at its 33rd session, Considering that the aim of UNESCO is to contribute to peace and security by promoting collaboration among nations through education, science and culture, Referring to existing international instruments relating to human rights, Aware of resolution 58/5 adopted by the General Assembly of the United Nations on 3 November 2003, concerning sport as a means to promote education, health, development and peace, notably its paragraph 7, Conscious that sport should play an important role in the protection of health, in moral, cultural and physical education and in promoting international understanding and peace, Noting the need to encourage and coordinate international cooperation towards the elimination of doping in sport, Concerned by the use of doping by athletes in sport and the consequences thereof for their health, the principle of fair play, the elimination of cheating and the future of sport, Mindful that doping puts at risk the ethical principles and educational values embodied in the International Charter of Physical Education and Sport of UNESCO and in the Olympic Charter, Recalling that the Anti-Doping Convention and its Additional Protocol adopted within the framework of the Council of Europe are the public international law tools which are at the origin of national anti-doping policies and of intergovernmental cooperation, Recalling the recommendations on doping adopted by the second, third and fourth International Conferences of Ministers and Senior Officials Responsible for Physical Education and Sport organized by UNESCO at Moscow (1988), Punta del Este

(1999)and Athens

(2004)and 32 C/Resolution 9 adopted by the General Conference of UNESCO at its 32nd session (2003), Bearing in mind the World Anti-Doping Code adopted by the World Anti-Doping Agency at the World Conference on Doping in Sport, Copenhagen, 5 March 2003, and the Copenhagen Declaration on Anti-Doping in Sport, Mindful also of the influence that elite athletes have on youth, Aware of the ongoing need to conduct and promote research with the objectives of improving detection of doping and better understanding of the factors affecting use in order for prevention strategies to be most effective, Aware also of the importance of ongoing education of athletes, athlete support personnel and the community at large in preventing doping, Mindful of the need to build the capacity of States Parties to implement anti-doping programmes, Aware that public authorities and the organizations responsible for sport have complementary responsibilities to prevent and combat doping in sport, notably to ensure the proper conduct, on the basis of the principle of fair play, of sports events and to protect the health of those that take part in them, Recognizing that these authorities and organizations must work together for these purposes, ensuring the highest degree of independence and transparency at all appropriate levels, Determined to take further and stronger cooperative action aimed at the elimination of doping in sport, Recognizing that the elimination of doping in sport is dependent in part upon progressive harmonization of anti-doping standards and practices in sport and cooperation at the national and global levels, Adopts this Convention on this nineteenth day of October 2005. The purpose of this Convention, within the framework of the strategy and programme of activities of UNESCO in the area of physical education and sport, is to promote the prevention of and the fight against doping in sport, with a view to its elimination. These definitions are to be understood within the context of the World Anti-Doping Code. However, in case of conflict the provisions of the Convention will prevail. For the purposes of this Convention: 1. “Accredited doping control laboratories” means laboratories accredited by the World Anti-Doping Agency. 2. “Anti-doping organization” means an entity that is responsible for adopting rules for initiating, implementing or enforcing any part of the doping control process. This includes, for example, the International Olympic Committee, the International Paralympic Committee, other major event organizations that conduct testing at their events, the World Anti-Doping Agency, international federations and national antidoping organizations. 3. “Anti-doping rule violation” in sport means one or more of the following: (a) the presence of a prohibited substance or its metabolites or markers in an athlete’s bodily specimen; (b) use or attempted use of a prohibited substance or a prohibited method; (c) refusing, or failing without compelling justification, to submit to sample collection after notification as authorized in applicable anti-doping rules or otherwise evading sample collection; (d) violation of applicable requirements regarding athlete availability for out-of-competition testing, including failure to provide required whereabouts information and missed tests which are declared based on reasonable rules; (e) tampering, or attempting to tamper, with any part of doping control; (f) possession of prohibited substances or methods; (g) trafficking in any prohibited substance or prohibited method; (h) administration or attempted administration of a prohibited substance or prohibited method to any athlete, or assisting, encouraging, aiding, abetting, covering up or any other type of complicity involving an anti-doping rule violation or any attempted violation. 4. “Athlete” means, for the purposes of doping control, any person who participates in sport at the international or national level as defined by each national anti-doping organization and accepted by States Parties and any additional person who participates in a sport or event at a lower level accepted by States Parties. For the purposes of education and training programmes, “athlete” means any person who participates in sport under the authority of a sports organization. 5. “Athlete support personnel” means any coach, trainer, manager, agent, team staff, official, medical or paramedical personnel working with or treating athletes participating in or preparing for sports competition. 6. “Code” means the World Anti-Doping Code adopted by the World Anti-Doping Agency on 5 March 2003 at Copenhagen which is attached as Appendix 1 to this Convention. 7. “Competition” means a single race, match, game or singular athletic contest. 8. “Doping control” means the process including test distribution planning, sample collection and handling, laboratory analysis, results management, hearings and appeals. 9. “Doping in sport” means the occurrence of an anti-doping rule violation. 10. “Duly authorized doping control teams” means doping control teams operating under the authority of international or national anti-doping organizations. 11. “In-competition” testing means, for purposes of differentiating between in-competition and out-of-competition testing, unless provided otherwise in the rules of an international federation or other relevant anti-doping organization, a test where an athlete is selected for testing in connection with a specific competition. 12. “International Standard for Laboratories” means the standard which is attached as Appendix 2 to this Convention. 13. “International Standard for Testing” means the standard which is attached as Appendix 3 to this Convention. 14. “No advance notice” means a doping control which takes place with no advance warning to the athlete and where the athlete is continuously chaperoned from the moment of notification through sample provision. 15. “Olympic Movement” means all those who agree to be guided by the Olympic Charter and who recognize the authority of the International Olympic Committee, namely the international federations of sports on the programme of the Olympic Games, the National Olympic Committees, the Organizing Committees of the Olympic Games, athletes, judges and referees, associations and clubs, as well as all the organizations and institutions recognized by the International Olympic Committee. 16. “Out-of-competition” doping control means any doping control which is not conducted in competition. 17. “Prohibited List” means the list which appears in Annex I to this Convention identifying the prohibited substances and prohibited methods. 18. “Prohibited method” means any method so described on the Prohibited List, which appears in Annex I to this Convention. 19. “Prohibited substance” means any substance so described on the Prohibited List, which appears in Annex I to this Convention. 20. “Sports organization” means any organization that serves as the ruling body for an event for one or several sports. 21. “Standards for Granting Therapeutic Use Exemptions” means those standards that appear in Annex II to this Convention. 22. “Testing” means the parts of the doping control process involving test distribution planning, sample collection, sample handling and sample transport to the laboratory. 23. “Therapeutic use exemption” means an exemption granted in accordance with Standards for Granting Therapeutic Use Exemptions. 24. “Use” means the application, ingestion, injection or consumption by any means whatsoever of any prohibited substance or prohibited method. 25. “World Anti-Doping Agency” (WADA) means the foundation so named established under Swiss law on 10 November 1999. In order to achieve the purpose of the Convention, States Parties undertake to: (a) adopt appropriate measures at the national and international levels which are consistent with the principles of the Code; (b) encourage all forms of international cooperation aimed at protecting athletes and ethics in sport and at sharing the results of research; (c) foster international cooperation between States Parties and leading organizations in the fight against doping in sport, in particular with the World Anti-Doping Agency. 1. In order to coordinate the implementation, at the national and international levels, of the fight against doping in sport, States Parties commit themselves to the principles of the Code as the basis for the measures provided for in Article 5 of this Convention. Nothing in this Convention prevents States Parties from adopting additional measures complementary to the Code. 2. The Code and the most current version of Appendices 2 and 3 are reproduced for information purposes and are not an integral part of this Convention. The Appendices as such do not create any binding obligations under international law for States Parties. 3. The Annexes are an integral part of this Convention. In abiding by the obligations contained in this Convention, each State Party undertakes to adopt appropriate measures. Such measures may include legislation, regulation, policies or administrative practices. This Convention shall not alter the rights and obligations of States Parties which arise from other agreements previously concluded and consistent with the object and purpose of this Convention. This does not affect the enjoyment by other States Parties of their rights or the performance of their obligations under this Convention. States Parties shall ensure the application of the present Convention, notably through domestic coordination. To meet their obligations under this Convention, States Parties may rely on anti-doping organizations as well as sports authorities and organizations. 1. States Parties shall, where appropriate, adopt measures to restrict the availability of prohibited substances and methods in order to restrict their use in sport by athletes, unless the use is based upon a therapeutic use exemption. These include measures against trafficking to athletes and, to this end, measures to control production, movement, importation, distribution and sale. 2. States Parties shall adopt, or encourage, where appropriate, the relevant entities within their jurisdictions to adopt measures to prevent and to restrict the use and possession of prohibited substances and methods by athletes in sport, unless the use is based upon a therapeutic use exemption. 3. No measures taken pursuant to this Convention will impede the availability for legitimate purposes of substances and methods otherwise prohibited or controlled in sport. States Parties shall themselves take measures or encourage sports organizations and antidoping organizations to adopt measures, including sanctions or penalties, aimed at athlete support personnel who commit an anti-doping rule violation or other offence connected with doping in sport. States Parties, where appropriate, shall encourage producers and distributors of nutritional supplements to establish best practices in the marketing and distribution of nutritional supplements, including information regarding their analytic composition and quality assurance. States Parties shall, where appropriate: (a) provide funding within their respective budgets to support a national testing programme across all sports or assist sports organizations and anti-doping organizations in financing doping controls either by direct subsidies or grants, or by recognizing the costs of such controls when determining the overall subsidies or grants to be awarded to those organizations; (b) take steps to withhold sport-related financial support to individual athletes or athlete support personnel who have been suspended following an anti-doping rule violation, during the period of their suspension; (c) withhold some or all financial or other sport-related support from any sports organization or anti-doping organization not in compliance with the Code or applicable anti-doping rules adopted pursuant to the Code. States Parties shall, where appropriate: (a) encourage and facilitate the implementation by sports organizations and antidoping organizations within their jurisdiction of doping controls in a manner consistent with the Code, including no-advance notice, out-of-competition and incompetition testing; (b) encourage and facilitate the negotiation by sports organizations and anti-doping organizations of agreements permitting their members to be tested by duly authorized doping control teams from other countries; (c) undertake to assist the sports organizations and anti-doping organizations within their jurisdiction in gaining access to an accredited doping control laboratory for the purposes of doping control analysis. States Parties shall encourage cooperation between anti-doping organizations, public authorities and sports organizations within their jurisdiction and those within the jurisdiction of other States Parties in order to achieve, at the international level, the purpose of this Convention. States Parties undertake to support the important mission of the World Anti-Doping Agency in the international fight against doping. States Parties support the principle of equal funding of the World Anti-Doping Agency’s approved annual core budget by public authorities and the Olympic Movement. Recognizing that the fight against doping in sport can only be effective when athletes can be tested with no advance notice and samples can be transported in a timely manner to laboratories for analysis, States Parties shall, where appropriate and in accordance with domestic law and procedures: (a) facilitate the task of the World Anti-Doping Agency and anti-doping organizations operating in compliance with the Code, subject to relevant host countries’ regulations, of conducting in- or out-of-competition doping controls on their athletes, whether on their territory or elsewhere; (b) facilitate the timely movement of duly authorized doping control teams across borders when conducting doping control activities; (c) cooperate to expedite the timely shipping or carrying across borders of samples in such a way as to maintain their security and integrity; (d) assist in the international coordination of doping controls by various anti-doping organizations, and cooperate to this end with the World Anti-Doping Agency; (e) promote cooperation between doping control laboratories within their jurisdiction and those within the jurisdiction of other States Parties. In particular, States Parties with accredited doping control laboratories should encourage laboratories within their jurisdiction to assist other States Parties in enabling them to acquire the experience, skills and techniques necessary to establish their own laboratories should they wish to do so; (f) encourage and support reciprocal testing arrangements between designated antidoping organizations, in conformity with the Code; (g) mutually recognize the doping control procedures and test results management, including the sport sanctions thereof, of any anti-doping organization that are consistent with the Code. 1. A “Fund for the Elimination of Doping in Sport”, hereinafter referred to as “the Voluntary Fund”, is hereby established. The Voluntary Fund shall consist of funds-intrust established in accordance with the Financial Regulations of UNESCO. All contributions by States Parties and other actors shall be voluntary. 2. The resources of the Voluntary Fund shall consist of: (a) contributions made by States Parties; (b) contributions, gifts or bequests which may be made by: (i) other States; (ii) organizations and programmes of the United Nations system, particularly the United Nations Development Programme, as well as other international organizations; (iii) public or private bodies or individuals; (c) any interest due on the resources of the Voluntary Fund; (d) funds raised through collections, and receipts from events organized for the benefit of the Voluntary Fund; (e) any other resources authorized by the Voluntary Fund’s regulations, to be drawn up by the Conference of Parties. 3. Contributions into the Voluntary Fund by States Parties shall not be considered to be a replacement for States Parties’ commitment to pay their share of the World Anti- Doping Agency’s annual budget. Resources in the Voluntary Fund shall be allocated by the Conference of Parties for the financing of activities approved by it, notably to assist States Parties in developing and implementing anti-doping programmes, in accordance with the provisions of this Convention, taking into consideration the goals of the World Anti-Doping Agency, and may serve to cover functioning costs of this Convention. No political, economic or other conditions may be attached to contributions made to the Voluntary Fund. 1. States Parties shall undertake, within their means, to support, devise or implement education and training programmes on anti-doping. For the sporting community in general, these programmes should aim to provide updated and accurate information on: (a) the harm of doping to the ethical values of sport; (b) the health consequences of doping. 2. For athletes and athlete support personnel, in particular in their initial training, education and training programmes should, in addition to the above, aim to provide updated and accurate information on: (a) doping control procedures; (b) athletes’ rights and responsibilities in regard to anti-doping, including information about the Code and the anti-doping policies of the relevant sports and anti-doping organizations. Such information shall include the consequences of committing an anti-doping rule violation; (c) the list of prohibited substances and methods and therapeutic use exemptions; (d) nutritional supplements. States Parties shall encourage relevant competent professional associations and institutions to develop and implement appropriate codes of conduct, good practice and ethics related to antidoping in sport that are consistent with the Code. States Parties shall promote and, within their means, support active participation by athletes and athlete support personnel in all facets of the anti-doping work of sports and other relevant organizations and encourage sports organizations within their jurisdiction to do likewise. States Parties shall encourage sports organizations and anti-doping organizations to implement ongoing education and training programmes for all athletes and athlete support personnel on the subjects identified in Article 19. States Parties shall cooperate mutually and with the relevant organizations to share, where appropriate, information, expertise and experience on effective anti-doping programmes. States Parties undertake, within their means, to encourage and promote anti-doping research in cooperation with sports and other relevant organizations on: (a) prevention, detection methods, behavioural and social aspects, and the health consequences of doping; (b) ways and means of devising scientifically-based physiological and psychological training programmes respectful of the integrity of the person; (c) the use of all emerging substances and methods resulting from scientific developments. When promoting anti-doping research, as set out in Article 24, States Parties shall ensure that such research will: (a) comply with internationally recognized ethical practices; (b) avoid the administration to athletes of prohibited substances and methods; (c) be undertaken only with adequate precautions in place to prevent the results of anti-doping research being misused and applied for doping. Subject to compliance with applicable national and international law, States Parties shall, where appropriate, share the results of available anti-doping research with other States Parties and the World Anti-Doping Agency. States Parties shall encourage: (a) members of the scientific and medical communities to carry out sport science research in accordance with the principles of the Code; (b) sports organizations and athlete support personnel within their jurisdiction to implement sport science research that is consistent with the principles of the Code. 1. A Conference of Parties is hereby established. The Conference of Parties shall be the sovereign body of this Convention. 2. The Conference of Parties shall meet in ordinary session in principle every two years. It may meet in extraordinary session if it so decides or at the request of at least one third of the States Parties. 3. Each State Party shall have one vote at the Conference of Parties. 4. The Conference of Parties shall adopt its own Rules of Procedure. The World Anti-Doping Agency shall be invited as an advisory organization to the Conference of Parties. The International Olympic Committee, the International Paralympic Committee, the Council of Europe and the Intergovernmental Committee for Physical Education and Sport (CIGEPS) shall be invited as observers. The Conference of Parties may decide to invite other relevant organizations as observers. 1. Besides those set forth in other provisions of this Convention, the functions of the Conference of Parties shall be to: (a) promote the purpose of this Convention; (b) discuss the relationship with the World Anti-Doping Agency and study the mechanisms of funding of the Agency’s annual core budget. States non-Parties may be invited to the discussion; (c) adopt a plan for the use of the resources of the Voluntary Fund, in accordance with Article 18; (d) examine the reports submitted by States Parties in accordance with Article 31; (e) examine, on an ongoing basis, the monitoring of compliance with this Convention in response to the development of anti-doping systems, in accordance with Article 31. Any monitoring mechanism or measure that goes beyond Article 31 shall be funded through the Voluntary Fund established under Article 17; (f) examine draft amendments to this Convention for adoption; (g) examine for approval, in accordance with Article 34 of the Convention, modifications to the Prohibited List and to the Standards for Granting Therapeutic Use Exemptions adopted by the World Anti-Doping Agency; (h) define and implement cooperation between States Parties and the World Anti- Doping Agency within the framework of this Convention; (i) request a report from the World Anti-Doping Agency on the implementation of the Code to each of its sessions for examination. 2. The Conference of Parties, in fulfilling its functions, may cooperate with other intergovernmental bodies. States Parties shall forward every two years to the Conference of Parties through the Secretariat, in one of the official languages of UNESCO, all relevant information concerning measures taken by them for the purpose of complying with the provisions of this Convention. 1. The secretariat of the Conference of Parties shall be provided by the Director-General of UNESCO. 2. At the request of the Conference of Parties, the Director-General of UNESCO shall use to the fullest extent possible the services of the World Anti-Doping Agency on terms agreed upon by the Conference of Parties. 3. Functioning costs related to the Convention will be funded from the regular budget of UNESCO within existing resources at an appropriate level, the Voluntary Fund established under Article 17 or an appropriate combination thereof as determined every two years. The financing for the secretariat from the regular budget shall be done on a strictly minimal basis, it being understood that voluntary funding should also be provided to support the Convention. 4. The secretariat shall prepare the documentation of the Conference of Parties, as well as the draft agenda of its meetings, and shall ensure the implementation of its decisions. 1. Each State Party may, by written communication addressed to the Director-General of UNESCO, propose amendments to this Convention. The Director-General shall circulate such communication to all States Parties. If, within six months from the date of the circulation of the communication, at least one half of the States Parties give their consent, the Director-General shall present such proposals to the following session of the Conference of Parties. 2. Amendments shall be adopted by the Conference of Parties with a two-thirds majority of States Parties present and voting. 3. Once adopted, amendments to this Convention shall be submitted for ratification, acceptance, approval or accession to States Parties. 4. With respect to the States Parties that have ratified, accepted, approved or acceded to them, amendments to this Convention shall enter into force three months after the deposit of the instruments referred to in paragraph 3 of this Article by two thirds of theStates Parties. Thereafter, for each State Party that ratifies, accepts, approves or accedes to an amendment, the said amendment shall enter into force three months after the date of deposit by that State Party of its instrument of ratification, acceptance, approval or accession. 5. A State that becomes a Party to this Convention after the entry into force of amendments in conformity with paragraph 4 of this Article shall, failing an expression of different intention, be considered: (a) a Party to this Convention as so amended; (b) a Party to the unamended Convention in relation to any State Party not bound by the amendments. 1. If the World Anti-Doping Agency modifies the Prohibited List or the Standards for Granting Therapeutic Use Exemptions, it may, by written communication addressed to the Director-General of UNESCO, inform her/him of those changes. The Director- General shall notify such changes as proposed amendments to the relevant Annexes to this Convention to all States Parties expeditiously. Amendments to the Annexes shall be approved by the Conference of Parties either at one of its sessions or through a written consultation. 2. States Parties have 45 days from the Director-General’s notification within which to express their objection to the proposed amendment either in writing, in case of written consultation, to the Director-General or at a session of the Conference of Parties. Unless two thirds of the States Parties express their objection, the proposed amendment shall be deemed to be approved by the Conference of Parties. 3. Amendments approved by the Conference of Parties shall be notified to States Parties by the Director-General. They shall enter into force 45 days after that notification, except for any State Party that has previously notified the Director-General that it does not accept these amendments. 4. A State Party having notified the Director-General that it does not accept an amendment approved according to the preceding paragraphs remains bound by the Annexes as not amended. The following provisions shall apply to States Parties that have a federal or non-unitary constitutional system: (a) with regard to the provisions of this Convention, the implementation of which comes under the legal jurisdiction of the federal or central legislative power, the obligations of the federal or central government shall be the same as for those States Parties which are not federal States; (b) with regard to the provisions of this Convention, the implementation of which comes under the jurisdiction of individual constituent States, counties, provinces or cantons which are not obliged by the constitutional system of the federation to take legislative measures, the federal government shall inform the competent authorities of such States, counties, provinces or cantons of the said provisions, with its recommendation for their adoption. This Convention shall be subject to ratification, acceptance, approval or accession by States Members of UNESCO in accordance with their respective constitutional procedures. The instruments of ratification, acceptance, approval or accession shall be deposited with the Director-General of UNESCO. 1. This Convention shall enter into force on the first day of the month following the expiration of a period of one month after the date of deposit of the thirtieth instrument of ratification, acceptance, approval or accession. 2. For any State that subsequently expresses its consent to be bound by it, the Convention shall enter into force on the first day of the month following the expiration of a period of one month after the date of deposit of its instrument of ratification, acceptance, approval or accession. 1. Any State may, when depositing its instrument of ratification, acceptance, approval or accession, specify the territory or territories for whose international relations it is responsible and to which this Convention shall apply. 2. Any State Party may, at any later date, by a declaration addressed to UNESCO, extend the application of this Convention to any other territory specified in the declaration. In respect of such territory the Convention shall enter into force on the first day of the month following the expiration of a period of one month after the date of receipt of such declaration by the depositary. 3. Any declaration made under the two preceding paragraphs may, in respect of any territory specified in such declaration, be withdrawn by a notification addressed to UNESCO. Such withdrawal shall become effective on the first day of the month following the expiration of a period of one month after the date of receipt of such a notification by the depositary. Any State Party may denounce this Convention. The denunciation shall be notified by an instrument in writing, deposited with the Director-General of UNESCO. The denunciation shall take effect on the first day of the month following the expiration of a period of six months after the receipt of the instrument of denunciation. It shall in no way affect the financial obligations of the State Party concerned until the date on which the withdrawal takes effect. The Director-General of UNESCO shall be the Depositary of this Convention and amendments thereto. As the Depositary, the Director-General of UNESCO shall inform the States Parties to this Convention, as well as the other States Members of the Organization of: (a) the deposit of any instrument of ratification, acceptance, approval or accession; (b) the date of entry into force of this Convention in accordance with Article 37; (c) any report prepared in pursuance of the provisions of Article 31; (d) any amendment to the Convention or to the Annexes adopted in accordance with Articles 33 and 34 and the date on which the amendment comes into force; (e) any declaration or notification made under the provisions of Article 38; (f) any notification made under the provisions of Article 39 and the date on which the denunciation takes effect; (g) any other act, notification or communication relating to this Convention. In conformity with Article 102 of the Charter of the United Nations, this Convention shall be registered with the Secretariat of the United Nations at the request of the Director-General of UNESCO. 1. This Convention, including its Annexes, has been drawn up in Arabic, Chinese, English, French, Russian and Spanish, the six texts being equally authoritative. 2. The Appendices to this Convention are provided in Arabic, Chinese, English, French, Russian and Spanish. No reservations that are incompatible with the object and purpose of the present Convention shall be permitted. Annex I – The Prohibited List – International Standard Annex II – Standards for Granting Therapeutic Use Exemptions Appendix 1 – World Anti-Doping Code Appendix 2 – International Standard for Laboratories Appendix 3 – International Standard for Testing The official text of the Prohibited List shall be maintained by the World Anti-Doping Agency (WADA) and shall be published in English and French. In the event of any conflict between the English and French versions, the English version shall prevail. The use of any drug should be limited to medically justified indications S1. ANABOLIC AGENTS Anabolic agents are prohibited. 1. Anabolic Androgenic Steroids (AAS) (a) Exogenous* AAS, including: 18alfa-homo-17beta-hydroxyestr-4-en-3-one; bolasterone; boldenone; boldione; calusterone; clostebol; danazol; dehydrochloromethyl-testosterone; delta1-androstene-3,17-dione; delta1-androstenediol; delta1-dihydro-testosterone; drostanolone; ethylestrenol; fluoxymesterone; formebolone; furazabol; gestrinone; 4-hydroxytestosterone; 4-hydroxy-19-nortestosterone; mestanolone; mesterolone; metenolone; methandienone; methandriol; methyldienolone; methyltrienolone; methyltestosterone; mibolerone; nandrolone; 19-norandrostenediol; 19-norandrostenedione; norbolethone; norclostebol; norethandrolone; oxabolone; oxandrolone; oxymesterone; oxymetholone; quinbolone; stanozolol; stenbolone; tetrahydrogestrinone; trenbolone and other substances with a similar chemical structure or similar biological effect(s). (b) Endogenous** AAS: androstenediol (androst-5-ene-3beta,17beta-diol); androstenedione (androst-4-ene-3,17-dione); dehydroepiandrosterone (DHEA); dihydro-testosterone; testosterone and the following metabolites and isomers: 5alfa-androstane-3 alfa,17alfa-diol; 5alfa-androstane-3alfa, 17beta-diol; 5alfa-androstane-3beta,17alfa-diol; 5alfa-androstane-3beta,17beta-diol; androst-4-ene-3alfa,17alfa-diol; androst-4-ene-3alfa,17beta-diol; androst-4-ene-3beta,17alfa-diol; androst-5-ene-3alfa,17alfa-diol; androst-5-ene-3alfa,17beta-diol; androst-5-ene-3beta,17alfa-diol; 4-androstenediol (androst-4-ene-3beta,17beta-diol); 5 androstenedione (androst-5-ene-3,17-dione); epi-dihydrotestosterone; 3alfa-hydroxy-5alfa-androstan-17-one; 3beta-hydroxy-5alfa-androstan-17-one; 19-norandro-sterone; 19-noretiocholanolone. Where a Prohibited Substance (as listed above) is capable of being produced by the body naturally, a Sample will be deemed to contain such Prohibited Substance where the concentration of the Prohibited Substance or its metabolites or markers and/or any other relevant ratio(s) in the Athlete’s Sample so deviates from the range of values normally found in humans that it is unlikely to be consistent with normal endogenous production. A Sample shall not be deemed to contain a Prohibited Substance in any such case where the Athlete proves by evidence that the concentration of the Prohibited Substance or its metabolites or markers and/or the relevant ratio(s) in the Athlete’s Sample is attributable to a physiological or pathological condition. In all cases, and at any concentration, the laboratory will report an Adverse Analytical Finding if, based on any reliable analytical method, it can show that the Prohibited Substance is of exogenous origin. If the laboratory result is not conclusive and no concentration as referred to in the above paragraph is found, the relevant Anti-Doping Organization shall conduct a further investigation if there are serious indications, such as a comparison to reference steroid profiles, for a possible Use of a Prohibited Substance. If the laboratory has reported the presence of a T/E ratio greater than four

(4)to one

(1)in the urine, further investigation is obligatory in order to determine whether the ratio is due to a physiological or pathological condition, except if the laboratory reports an Adverse Analytical Finding based on any reliable analytical method, showing that the Prohibited Substance is of exogenous origin. In case of an investigation, it will include a review of any previous and/or subsequent tests. If previous tests are not available, the Athlete shall be tested unannounced at least three times within a three month period. Should an Athlete fail to cooperate in the investigations, the Athlete’s Sample shall be deemed to contain a Prohibited Substance. 2. Other Anabolic Agents, including but not limited to: Clenbuterol, zeranol, zilpaterol. For the purposes of this section: * “exogenous” refers to a substance which is not capable of being produced by the body naturally. ** “endogenous” refers to a substance which is capable of being produced by the body naturally. S2. HORMONES AND RELATED SUBSTANCES The following substances, including other substances with a similar chemical structure or similar biological effect(s), and their releasing factors are prohibited: 1. Erythropoietin (EPO); 2. Growth Hormone (hGH), Insulin-like Growth Factor (IGF-1), Mechano Growth Factors (MGFs); 3. Gonadotrophins (LH, hCG); 4. Insulin; 5. Corticotrophins. Unless the Athlete can demonstrate that the concentration was due to a physiological or pathological condition, a Sample will be deemed to contain a Prohibited Substance (as listed above) where the concentration of the Prohibited Substance or its metabolites and/or relevant ratios or markers in the Athlete’s Sample so exceeds the range of values normally found in humans that it is unlikely to be consistent with normal endogenous production. The presence of other substances with a similar chemical structure or similar biological effect(s), diagnostic marker(s) or releasing factors of a hormone listed above or of any other finding which indicate(s) that the substance detected is of exogenous origin, will be reported as an Adverse Analytical Finding. S3. BETA-2 AGONISTS All beta-2 agonists including their D- and L-isomers are prohibited. Their use requires a Therapeutic Use Exemption. As an exception, formoterol, salbutamol, salmeterol and terbutaline, when administered by inhalation to prevent and/or treat asthma and exercise-induced asthma/broncho-constriction require an abbreviated Therapeutic Use Exemption. Despite the granting of a Therapeutic Use Exemption, when the Laboratory has reported a concentration of salbutamol (free plus glucuronide) greater than 1000 ng/mL, this will be considered to be an Adverse Analytical Finding unless the athlete proves that the abnormal result was the consequence of the therapeutic use of inhaled salbutamol. S4. AGENTS WITH ANTI-ESTROGENIC ACTIVITY The following classes of anti-estrogenic substances are prohibited. 1. Aromatase inhibitors including, but not limited to, anastrozole, letrozole, aminogluthetimide, exemestane, formestane, testolactone. 2. Selective Estrogen Receptor Modulators (SERMs) including, but not limited to, raloxifene, tamoxifen, toremifene. 3. Other anti-estrogenic substances including, but not limited to, clomiphene, cyclofenil, fulvestrant. S5. DIURETICS AND OTHER MASKING AGENTS Diuretics and other masking agents are prohibited. Masking agents include but are not limited to: diuretics*, epitestosterone, probenecid, alpha-reductase inhibitors (e.g. finasteride, dutasteride), plasma expanders (e.g. albumin, dextran, hydroxyethyl starch). Diuretics include: acetazolamide, amiloride, bumetanide, canrenone, chlortalidone, etacrynic acid, furosemide, indapamide, metolazone, spironolactone, thiazides (e.g. bendroflumethiazide, chlorothiazide, hydrochlorothiazide), triamterene and other substances with a similar chemical structure or similar biological effect(s). *A Therapeutic Use Exemption is not valid if an Athlete’s urine contains a diuretic in association with threshold or sub-threshold levels of a Prohibited Substance(s). M1. ENHANCEMENT OF OXYGEN TRANSFER The following are prohibited. (a) Blood doping, including the use of autologous, homologous or heterologous blood or red blood cell products of any origin, other than for medical treatment. (b) Artificially enhancing the uptake, transport or delivery of oxygen, including but not limited to perfluorochemicals, efaproxiral (RSR13) and modified haemoglobin products (e.g. haemoglobin-based blood substitutes, micro- encapsulated haemoglobin products). M2. CHEMICAL AND PHYSICAL MANIPULATION The following is prohibited: Tampering, or attempting to tamper, in order to alter the integrity and validity of Samples collected in Doping Controls. These include but are not limited to intravenous infusions*, catheterization, and urine substitution. * Except as a legitimate acute medical treatment, intravenous infusions are prohibited. M3. GENE DOPING The non-therapeutic use of cells, genes, genetic elements, or of the modulation of gene expression, having the capacity to enhance athletic performance, is prohibited. S6. STIMULANTS The following stimulants are prohibited, including both their optical (D- and L-) isomers where relevant: adrafinil, amfepramone, amiphenazole, amphetamine, amphetaminil, benzphetamine, bromantan, carphedon, cathine*, clobenzorex, cocaine, dimethylamphetamine, ephedrine**, etilamphetamine, etilefrine, famprofazone, fencamfamin, fencamine, fenetylline, fenfluramine, fenproporex, furfenorex, mefenorex, mephentermine, mesocarb, methamphetamine, methylamphetamine, methylenedioxyamphetamine, methylenedioxy-methamphetamine, methylephedrine**, methylphenidate, modafinil, nikethamide, norfenfluramine, parahydroxyamphetamine, pemoline, phendi-metrazine, phenmetrazine, phentermine, prolintane, selegiline, strychnine and other substances with a similar chemical structure or similar biological effect(s)***. * Cathine is prohibited when its concentration in urine is greater than 5 micrograms per milliliter. ** Each of ephedrine and methylephedrine is prohibited when its concentration in urine is greater than 10 micrograms per milliliter. *** The substances included in the 2005 Monitoring Programme (bupropion, caffeine, phenylephrine, phenylpropanolamine, pipradrol, pseudoephedrine, synephrine) are not considered as Prohibited Substances. NOTE: Adrenaline associated with local anaesthetic agents or by local administration (e.g. nasal, ophthalmologic) is not prohibited. S7. NARCOTICS The following narcotics are prohibited: buprenorphine, dextromoramide, diamorphine (heroin), fentanyl and its derivatives, hydromorphone, methadone, morphine, oxycodone, oxymorphone, pentazocine, pethidine. S8. CANNABINOIDS Cannabinoids (e.g. hashish, marijuana) are prohibited. S9. GLUCOCORTICOSTEROIDS All glucocorticosteroids are prohibited when administered orally, rectally, intravenously or intramuscularly. Their use requires a Therapeutic Use Exemption approval. All other routes of administration require an abbreviated Therapeutic Use Exemption. Dermatological preparations are not prohibited. P1. ALCOHOL Alcohol (ethanol) is prohibited in-competition only, in the following sports. Detection will be conducted by analysis of breath and/or blood. The doping violation threshold for each Federation is reported in parenthesis. – Aeronautic (FAI) (0.20 g/L) – Archery (FITA) (0.10 g/L) – Automobile (FIA) (0.10 g/L) – Billiards (WCBS) (0.20 g/L) – Boules (CMSB) (0.10 g/L) – Karate (WKF) (0.10 g/L) – Modern Pentathlon (UIPM) (0.10 g/L) for disciplines involving shooting – Motorcycling (FIM) (0.00 g/L) – Skiing (FIS) (0.10 g/L) P2. BETA-BLOCKERS Unless otherwise specified, beta-blockers are prohibited in-competition only, in the following sports. – Aeronautic (FAI)  – Archery (FITA) (also prohibited out-of-competition) – Automobile (FIA) – Billiards (WCBS) – Bobsleigh (FIBT) – Boules (CMSB) – Bridge (FMB) – Chess (FIDE) – Curling (WCF) – Gymnastics (FIG) – Motorcycling (FIM) – Modern Pentathlon (UIPM) for disciplines involving shooting – Nine-pin bowling (FIQ) – Sailing (ISAF) for match race helms only  – Shooting (ISSF) (also prohibited out-of-competition) – Skiing (FIS) in ski jumping and free style snow board – Swimming (FINA) in diving and synchronized swimming – Wrestling (FILA) Beta-blockers include, but are not limited to, the following: acebutolol, alprenolol, atenolol, betaxolol, bisoprolol, bunolol, carteolol, carvedilol, celiprolol, esmolol, labetalol, levobunolol, metipranolol, metoprolol, nadolol, oxprenolol, pindolol, propranolol, sotalol, timolol. “Specified Substances”* are listed below: ephedrine, L-methylamphetamine, methylephedrine; cannabinoids; all inhaled Beta-2 Agonists, except clenbuterol; probenecid; all Glucocorticosteroids; all Beta Blockers; alcohol. * “The Prohibited List may identify specified substances which are particularly susceptible to unintentional anti-doping rule violations because of their general availability in medicinal products or which are less likely to be successfully abused as doping agents.” A doping violation involving such substances may result in a reduced sanction provided that the “… Athlete can establish that the Use of such a specified substance was not intended to enhance sport performance …” 4.0 Criteria for granting a therapeutic use exemption A Therapeutic Use Exemption (TUE) may be granted to an Athlete permitting the use of a Prohibited Substance or Prohibited Method contained in the Prohibited List. An application for a TUE will be reviewed by a Therapeutic Use Exemption Committee (TUEC). The TUEC will be appointed by an Anti-Doping Organization. An exemption will be granted only in strict accordance with the following criteria: [Comment: This standard applies to all Athletes as defined by and subject to the Code i.e. able-bodied athletes and athletes with disabilities. This Standard will be applied according to an individual’s circumstances. For example, an exemption that is appropriate for an athlete with a disability may be inappropriate for other athletes.] 4.1 The Athlete should submit an application for a TUE no less than 21 days before participating in an Event. 4.2 The Athlete would experience a significant impairment to health if the Prohibited Substance or Prohibited Method were to be withheld in the course of treating an acute or chronic medical condition. 4.3 The therapeutic use of the Prohibited Substance or Prohibited Method would produce no additional enhancement of performance other than that which might be anticipated by a return to a state of normal health following the treatment of a legitimate medical condition. The use of any Prohibited Substance or Prohibited Method to increase “low-normal” levels of any endogenous hormone is not considered an acceptable therapeutic intervention. 4.4 There is no reasonable therapeutic alternative to the use of the otherwise Prohibited Substance or Prohibited Method. 4.5 The necessity for the use of the otherwise Prohibited Substance or Prohibited Method cannot be a consequence, wholly or in part, of prior non-therapeutic use of any substance from the Prohibited List. 4.6 The TUE will be cancelled by the granting body, if (a) the Athlete does not promptly comply with any requirements or conditions imposed by the Anti-Doping Organization granting the exemption; (b) the term for which the TUE was granted has expired; (c) the Athlete is advised that the TUE has been withdrawn by the Anti-Doping Organization. [Comment: Each TUE will have a specified duration as decided upon by the TUEC. There may be cases when a TUE has expired or has been withdrawn and the Prohibited Substance subject to the TUE is still present in the Athlete’s body. In such cases, the Anti-Doping Organization conducting the initial review of an adverse finding will consider whether the finding is consistent with expiry or withdrawal of the TUE.] 4.7 An application for a TUE will not be considered for retroactive approval except in cases where: (a) emergency treatment or treatment of an acute medical condition was necessary; or (b) due to exceptional circumstances, there was insufficient time or opportunity for an applicant to submit, or a TUEC to consider, an application prior to Doping Control. [Comment: Medical Emergencies or acute medical situations requiring administration of an otherwise Prohibited Substance or Prohibited Method before an application for a TUE can be made, are uncommon. Similarly, circumstances requiring expedited consideration of an application for a TUE due to imminent competition are infrequent. Anti-Doping Organizations granting TUEs should have internal procedures which permit such situations to be addressed.] 5.0. Confidentiality of information 5.1 The applicant must provide written consent for the transmission of all information pertaining to the application to members of the TUEC and, as required, other independent medical or scientific experts, or to all necessary staff involved in the management, review or appeal of TUEs. Should the assistance of external, independent experts be required, all details of the application will be circulated without identifying the Athlete involved in the Athlete’s care. The applicant must also provide written consent for the decisions of the TUEC to be distributed to other relevant Anti-Doping Organizations under the provisions of the Code. 5.2 The members of the TUECs and the administration of the Anti-Doping Organization involved will conduct all of their activities in strict confidence. All members of a TUEC and all staff involved will sign confidentiality agreements. In particular they will keep the following information confidential: (a) all medical information and data provided by the Athlete and physician(s) involved in the Athlete’s care; (b) all details of the application including the name of the physician(s) involved in the process. Should the Athlete wish to revoke the right of the TUEC or the WADA TUEC to obtain any health information on his/her behalf, the Athlete must notify his/her medical practitioner in writing of the fact. As a consequence of such a decision, the Athlete will not receive approval for a TUE or renewal of an existing TUE. 6.0 Therapeutic use exemption committees (TUECs) TUECs shall be constituted and act in accordance with the following guidelines: 6.1 TUECs should include at least three physicians with experience in the care and treatment of Athletes and a sound knowledge of clinical, sports and exercise medicine. In order to ensure a level of independence of decisions, a majority of the members of the TUEC should not have any official responsibility in the Anti-Doping Organization. All members of a TUEC will sign a conflict of interest agreement. In applications involving Athletes with disabilities, at least one TUEC member must possess specific experience with the care and treatment of Athletes with disabilities. 6.2 TUECs may seek whatever medical or scientific expertise they deem appropriate in reviewing the circumstances of any application for a TUE. 6.3 The WADA TUEC shall be composed following the criteria set out in Article 6.1. The WADA TUEC is established to review on its own initiative TUE decisions granted by Anti-Doping Organizations. As specified in Article 4.4 of the Code, the WADA TUEC, upon request by Athletes who have been denied TUEs by an Anti-Doping Organization will review such decisions with the power to reverse them. 7.0 Therapeutic use exemption (TUE) application process 7.1 A TUE will only be considered following the receipt of a completed application form that must include all relevant documents (see Appendix 1 – TUE form). The application process must be dealt with in accordance with the principles of strict medical confidentiality. 7.2 The TUE application form(s), as set out in Appendix 1, can be modified by Anti-Doping Organizations to include additional requests for information, but no sections or items shall be removed. 7.3 The TUE application form(s) may be translated into other language(s) by Anti-Doping Organizations, but English or French must remain on the application form(s). 7.4 An Athlete may not apply to more than one Anti-Doping Organization for a TUE. The application must identify the Athlete’s sport and, where appropriate, discipline and specific position or role. 7.5 The application must list any previous and/or current requests for permission to use an otherwise Prohibited Substance or Prohibited Method, the body to whom that request was made, and the decision of that body. 7.6 The application must include a comprehensive medical history and the results of all examinations, laboratory investigations and imaging studies relevant to the application. 7.7 Any additional relevant investigations, examinations or imaging studies requested by the TUEC of the Anti-Doping Organization will be undertaken at the expense of the applicant or his/her national sport governing body. 7.8 The application must include a statement by an appropriately qualified physician attesting to the necessity of the otherwise Prohibited Substance or Prohibited Method in the treatment of the Athlete and describing why an alternative, permitted medication cannot, or could not, be used in the treatment of this condition. 7.9 The dose, frequency, route and duration of administration of the otherwise Prohibited Substance or Prohibited Method in question must be specified. 7.10 Decisions of the TUEC, should be completed within 30 days of receipt of all relevant documentation and will be conveyed in writing to the Athlete by the relevant Anti- Doping Organization. Where a TUE has been granted to an Athlete in the Anti-Doping Organization Registered Testing Pool, the Athlete and WADA will be provided promptly with an approval which includes information pertaining to the duration of the exemption and any conditions associated with the TUE. 7.11 (a) Upon receiving a request by an Athlete for review, as specified in Article 4.4 of the Code, the WADA TUEC will, as specified in Article 4.4 of the Code, be able to reverse a decision on a TUE granted by an Anti-Doping Organization. The Athlete shall provide to the WADA TUEC all the information for a TUE as submitted initially to the Anti-Doping Organization accompanied by an application fee. Until the review process has been completed, the original decision remains in effect. The process should not take longer than 30 days following receipt of the information by WADA. (b) WADA can undertake a review at any time. The WADA TUEC will complete its review within 30 days. 7.12 If the decision regarding the granting of a TUE is reversed on review, the reversal shall not apply retroactively and shall not disqualify the Athlete’s results during the period that the TUE had been granted and shall take effect no later than 14 days following notification of the decision to the Athlete. 8.0 Abbreviated therapeutic use exemption (ATUE) application process 8.1 It is acknowledged that some substances included on the List of Prohibited Substances are used to treat medical conditions frequently encountered in the Athlete population. In such cases, a full application as detailed in section 4 and section 7 is unnecessary. Accordingly an abbreviated process of the TUE is established. 8.2 The Prohibited Substances or Prohibited Methods which may be permitted by this abbreviated process are strictly limited to the following: Beta-2 agonists (formoterol, salbutamol, salmeterol and terbutaline) by inhalation, and glucocorticosteroids by non-systemic routes. 8.3 To use one of the substances above, the Athlete shall provide to the Anti-Doping Organization a medical notification justifying the therapeutic necessity. Such medical notification, as contained in Appendix 2, shall describe the diagnosis, name of the drug, dosage, route of administration and duration of the treatment. When applicable any tests undertaken in order to establish the diagnosis should be included (without the actual results or details). 8.4 The abbreviated process includes: (a) approval for use of Prohibited Substances subject to the abbreviated process is effective upon receipt of a complete notification by the Anti-Doping Organization. Incomplete notifications must be returned to the applicant; (b) on receipt of a complete notification, the Anti-Doping Organization shall promptly advise the Athlete. As appropriate, the Athlete’s IF, NF and NADO shall also be advised. The Anti-Doping Organization shall advise WADA only upon receipt of a notification from an International-level Athlete; (c) a notification for an ATUE will not be considered for retroactive approval except: – if emergency treatment or treatment of an acute medical condition was necessary; or – due to exceptional circumstances, there was insufficient time or opportunity for an applicant to submit, or a TUEC to receive, an application prior to Doping Control. 8.5 (a) A review by the TUEC or the WADA TUEC can be initiated at any time during the duration of an ATUE. (b) If an Athlete requests a review of a subsequent denial of an ATUE, the WADA TUEC will have the ability to request from the Athlete additional medical information as deemed necessary, the expenses of which should be met by the Athlete. 8.6 An ATUE may be cancelled by the TUEC or WADA TUEC at any time. The Athlete, his/her IF and all relevant Anti-Doping Organizations shall be notified immediately. 8.7 The cancellation shall take effect immediately following notification of the decision to the Athlete. The Athlete will nevertheless be able to apply under section 7 for a TUE. 9.0 Clearing house 9.1 Anti-Doping Organizations are required to provide WADA with all TUEs, and all supporting documentation, issued under section 7. 9.2 With respect to ATUEs, Anti-Doping Organizations shall provide WADA with medical applications submitted by International-level Athletes issued under section 8.4 9.3 The Clearing house shall guarantee strict confidentiality of all the medical information. Generalna konferenca Organizacije združenih narodov za izobraževanje, znanost in kulturo, v nadaljevanju Unesco, ki se je v dneh od 3. do 21. oktobra 2005 sestala v Parizu na svojem 33. zasedanju, je ob upoštevanju, da je cilj Unesca prispevati k miru in varnosti s spodbujanjem sodelovanja med državami v izobraževanju, znanosti in kulturi, sklicujoč se na veljavne mednarodne listine o človekovih pravicah, zavedajoč se resolucije 58/5, ki jo je sprejela Generalna skupščina Združenih narodov 3. novembra 2003, o športu kot sredstvu za spodbujanje izobraževanja, zdravja, razvoja in miru, predvsem njenega sedmega odstavka, ker se zaveda, da mora šport imeti pomembno vlogo pri varovanju zdravja, moralni, kulturni in športni vzgoji ter spodbujanju mednarodnega razumevanja in miru, ob ugotavljanju potrebe po spodbujanju in usklajevanju mednarodnega sodelovanja za odpravo nedovoljenih snovi v športu, zaskrbljena, ker športniki uporabljajo nedovoljene snovi v športu in zaradi posledic uporabe za njihovo zdravje, načelo poštene igre, odpravo prevar in prihodnost športa, ker upošteva, da uporaba nedovoljenih snovi ogroža etična načela in vzgojne vrednote, zapisane v Mednarodni listini Unesca o športni vzgoji in športu ter Olimpijski listini, ker se sklicuje na to, da sta Konvencija proti uporabi nedovoljenih snovi in njen dodatni protokol, ki ga je sprejel Svet Evrope, javna mednarodnopravna dokumenta, ki sta podlaga nacionalnim protidopinškim politikam in medvladnemu sodelovanju, ob sklicevanju na priporočila proti uporabi nedovoljenih snovi, sprejetih na drugi, tretji in četrti Mednarodni konferenci ministrov in visokih uradnikov, odgovornih za športno vzgojo in šport, ki jih je Unesco organiziral v Moskvi (1988), Punti del Este

(1999)in Atenah (2004), in ob sklicevanju na resolucijo 32 C/9, ki jo je Generalna konferenca Unesca sprejela na svojem 32. zasedanju (2003), glede na Svetovni kodeks proti dopingu, ki ga je Svetovna protidopinška agencija sprejela na Svetovni konferenci o uporabi nedovoljenih snovi v športu 5. marca 2003 v Köbenhavnu, in glede na Köbenhavnsko deklaracijo proti dopingu v športu, ker se zaveda tudi vpliva, ki ga imajo elitni športniki na mladino, zavedajoč se stalne potrebe po raziskovanju in njegovem spodbujanju, da bi uspešneje odkrivali uporabo nedovoljenih snovi in boljše razumeli dejavnike, ki vplivajo na uporabo, in da bi bile strategije preprečevanja kar najučinkovitejše, zavedajoč se tudi pomena stalnega izobraževanja športnikov, spremljajočega osebja in širše skupnosti za preprečevanje uporabe nedovoljenih snovi, zavedajoč se potrebe po razvijanju zmožnosti držav pogodbenic za izvajanje protidopinških programov, ker se zavedajo, da imajo javne ustanove in organizacije, odgovorne za šport, dodatne obveznosti v zvezi s preprečevanjem uporabe nedovoljenih snovi v športu in boju proti njej, predvsem zaradi zagotavljanja primernega vodenja športnih dogodkov po načelu poštene igre in varovanja zdravja tistih, ki se športnih dogodkov udeležujejo, ob spoznanju, da morajo te ustanove in organizacije zaradi tega delovati skupaj ob zagotavljanju najvišje stopnje neodvisnosti in preglednosti na vseh ustreznih ravneh, odločena, da bo sprejela nadaljnje in odločnejše ukrepe za sodelovanje pri odpravljanju uporabe nedovoljenih snovi v športu, ob spoznanju, da je odprava uporabe nedovoljenih snovi v športu delno odvisna od postopne uskladitve protidopinških standardov in postopkov v športu in sodelovanja na državni in svetovni ravni, sprejela to konvencijo devetnajstega oktobra 2005. V okviru strategije in programa dejavnosti Unesca na področju športne vzgoje in športa je namen te konvencije spodbujati preprečevanje in boj proti uporabi nedovoljenih snovi v športu, da bi uporabo odpravili. Opredelitev izrazov je treba razumeti v okviru Svetovnega kodeksa proti dopingu. Ob neskladju pa se uporabljajo določbe konvencije. Posamezni izrazi v tej konvenciji pomenijo: 1. Izraz »akreditirani laboratoriji za analizo nedovoljenih snovi« pomeni laboratorije, akreditirane pri Svetovni protidopinški agenciji. 2. Izraz »protidopinška organizacija« pomeni pravno osebo, odgovorno za sprejemanje pravil o uvajanju, opravljanju ali izvajanju katerega koli dela postopka glede uporabe nedovoljenih snovi. To so na primer Mednarodni olimpijski komite, Mednarodni paraolimpijski komite, druge organizacije, ki pripravljajo pomembne športne prireditve in opravljajo testiranje, mednarodna združenja in nacionalne organizacije za boj proti uporabi nedovoljenih snovi. 3. Izraz »kršitev protidopinških pravil v športu« pomeni eno ali več kršitev: (a) prisotnost prepovedane snovi ali njenih presnovkov ali označevalcev v športnikovem biološkem vzorcu; (b) uporaba ali poskus uporabe prepovedane snovi ali prepovedanega postopka; (c) zavrnitev dajanja vzorca za preverjanje ali neizpolnitev zahteve za vzorec brez nujne utemeljitve razlogov, in to po uradnem obvestilu, odobrenem v veljavnih protidopinških pravilih, ali siceršnje izmikanje zbiranju vzorcev; (d) kršitev veljavnih zahtev, da morajo biti športniki na voljo za testiranje tudi takrat, ko ne tekmujejo, vključno z neizpolnitvijo zahteve, da povedo, na katerem naslovu so dosegljivi, in neuspelimi poskusi, ki po izjavah temeljijo na razumnih pravilih; (e) nedovoljeno spreminjanje ali poskusi spreminjanja katerega koli dela postopka nadzora nad uporabo nedovoljenih snovi; (f) posedovanje prepovedanih snovi in postopkov; (g) trgovanje s katero koli prepovedano snovjo ali prepovedanim postopkom; (h) dajanje ali poskus dajanja prepovedane snovi ali omogočanje prepovedanega postopka kateremu koli športniku ali pomoč, spodbujanje, napeljevanje, zakrivanje ali kakršna koli druga vrsta sokrivde, ki pomeni kršitev protidopinških pravil ali poskus take kršitve. 4. V postopku nadzora nad uporabo nedovoljenih snovi izraz »športnik« pomeni osebo, ki goji šport na mednarodni ali državni ravni, kot jo opredeli vsaka nacionalna protidopinška organizacija in jo sprejmejo države pogodbenice, in vsako drugo osebo, ki goji šport ali se udeležuje prireditve na nižji ravni, o njej pa se sporazumejo države pogodbenice. V programih izobraževanja in usposabljanja izraz »športnik« pomeni osebo, ki goji šport v športni organizaciji. 5. Izraz »spremljajoče osebje« pomeni trenerja, športnega učitelja, direktorja, zastopnika, moštveno osebje, funkcionarja, medicinsko ali paramedicinsko osebje, ki dela s športniki, ki se športnih tekmovanj udeležujejo ali pripravljajo nanje, ali športnike zdravstveno oskrbuje. 6. Izraz »kodeks« pomeni Svetovni kodeks proti dopingu, ki ga je Svetovna protidopinška agencija sprejela 5. marca 2003 v Köbenhavnu in je kot dodatek 1 priložen k tej konvenciji. 7. Izraz »tekmovanje« pomeni športni nastop, tekmo ali igro. 8. Izraz »nadzor nad uporabo nedovoljenih snovi« pomeni postopek, ki vključuje načrtovanje razporeda testiranj, zbiranje in obdelavo vzorcev, laboratorijsko analizo, ravnanje z izsledki, zaslišanja in pritožbe. 9. Izraz »uporaba nedovoljenih snovi v športu« pomeni kršitev protidopinških pravil. 10. Izraz »pooblaščene skupine za dopinški nadzor« pomeni skupine, ki dopinški nadzor opravljajo pod pristojnostjo mednarodnih ali državnih protidopinških organizacij. 11. Izraz »testiranje na tekmovanju« pomeni razlikovanje med testiranjem na tekmovanju in testiranjem zunaj tekmovanja, če ni drugače določeno v pravilih mednarodne zveze ali druge ustrezne protidopinške organizacije, preskus, pri katerem je športnik izbran za testiranje na tekmovanju. 12. Izraz »mednarodni standard za laboratorije« pomeni standard, ki je kot dodatek 2 priložen k tej konvenciji. 13. Izraz »mednarodni standard za testiranje« pomeni standard, ki je kot dodatek 3 priložen k tej konvenciji. 14. Izraz »brez vnaprejšnjega obvestila« pomeni postopek nadzora nad uporabo nedovoljenih snovi, ki se opravi, ne da bi bil športnik na to vnaprej opozorjen, in je pri tem športnik od trenutka prejema uradnega obvestila do oddaje vzorca nenehno pod nadzorom. 15. Izraz »olimpijsko gibanje« pomeni vse, ki soglašajo, da bodo upoštevali Olimpijsko listino, in priznavajo pristojnost Mednarodnega olimpijskega komiteja, to so mednarodne športne zveze za olimpijske igre, nacionalni olimpijski komiteji, organizacijski odbori olimpijskih iger, športniki, sodniki, društva in klubi ter vse organizacije in ustanove, ki jih priznava Mednarodni olimpijski komite. 16. Izraz »nadzor nad uporabo nedovoljenih snovi zunaj tekmovanja« pomeni nadzor nad uporabo nedovoljenih snovi, ki se ne opravlja med tekmovanjem. 17. Izraz »seznam prepovedanih snovi in postopkov 2005« pomeni seznam v prilogi 1 k tej konvenciji, v katerem so navedene prepovedane snovi in prepovedani postopki. 18. Izraz »prepovedani postopek« pomeni vsak postopek, ki je kot tak opisan na seznamu prepovedanih snovi in postopkov 2005 v prilogi 1 k tej konvenciji. 19. Izraz »prepovedana snov« pomeni vsako snov, navedeno oziroma opisano na seznamu prepovedanih snovi in postopkov 2005 v prilogi 1 k tej konvenciji. 20. Izraz »športna organizacija« pomeni vsako organizacijo, pristojno za posamezno prireditev, ki vključuje eno ali več športnih disciplin. 21. Izraz »standardi za priznanje terapevtskih izjem« pomeni standarde iz priloge 2 k tej konvenciji. 22. Izraz »testiranje« pomeni dele postopka dopinškega nadzora, ki vključujejo načrtovanje razporeda testiranj, zbiranje vzorcev, obdelavo in prevoz vzorcev v laboratorij. 23. Izraz »terapevtska izjema« pomeni izjemo, odobreno skladno s standardi za priznanje terapevtskih izjem. 24. Izraz »uporaba« pomeni nanos, zaužitje, vbrizg ali porabo na kakršen koli način katere koli prepovedane snovi ali uporabo katerega koli prepovedanega postopka. 25. Izraz »Svetovna protidopinška agencija« (SPA) pomeni ustanovo s tem imenom, ustanovljeno po švicarskem pravu 10. novembra 1999. Da bi dosegle namen konvencije, se pogodbenice zavezujejo, da bodo: (a) sprejele ustrezne ukrepe na državni in mednarodni ravni, skladne z načeli kodeksa; (b) spodbujale vse oblike mednarodnega sodelovanja, katerega cilj je varovanje športnikov, etika v športu in skupna uporaba izsledkov raziskav; (c) pospeševale sodelovanje med državami pogodbenicami in vodilnimi organizacijami pri boju proti uporabi nedovoljenih snovi v športu, predvsem s SPA. 1. Da bi lahko usklajevale boj proti uporabi nedovoljenih snovi v športu na državni in mednarodni ravni, se države pogodbenice zavezujejo, da bodo spoštovale načela kodeksa kot podlago za ukrepe iz 5. člena te konvencije. Nobena določba v tej konvenciji ne preprečuje državam pogodbenicam, da bi sprejele dodatne ukrepe, ki se dopolnjujejo s kodeksom. 2. Kodeks in najnovejša različica dodatkov 2 in 3 sta priložena v vednost in nista sestavni del te konvencije. Po mednarodnem pravu dodatka ne zavezujeta držav pogodbenic. 3. Priloge k temu sporazumu so sestavni del te konvencije. Pri izpolnjevanju obveznosti iz te konvencije se vsaka država pogodbenica zavezuje, da bo sprejela ustrezne ukrepe. Ukrepi lahko vključujejo zakonodajo, predpise, smernice ali upravne postopke. Ta konvencija ne vpliva na tiste pravice in obveznosti držav pogodbenic, ki izhajajo iz drugih že sklenjenih sporazumov in so usklajene z vsebino in namenom te konvencije. Ta določba ne vpliva na pravice, ki jih po tej konvenciji uživajo druge države pogodbenice, in ne vpliva na izpolnjevanje njihovih obveznosti po tej konvenciji. Države pogodbenice zagotavljajo uporabo te konvencije predvsem z notranjim usklajevanjem. Da bi izpolnile obveznosti po tej konvenciji, se države pogodbenice lahko oprejo na protidopinške organizacije, pa tudi na športne organe in organizacije. 1. Kadar je ustrezno, države pogodbenice sprejmejo ukrepe za omejevanje dostopnosti prepovedanih snovi in postopkov, da bi športnikom omejile njihovo uporabo v športu, razen če taka uporaba temelji na terapevtski izjemi. Med temi ukrepi so ukrepi zoper nedovoljeno prodajo športnikom in zaradi tega ukrepi za nadzor proizvodnje, pretoka, uvoza, razdeljevanja in prodaje. 2. Kadar je primerno, države pogodbenice sprejmejo ali spodbujajo ustrezne organizacije v svoji pristojnosti, da sprejmejo ukrepe, s katerimi športnikom preprečujejo in omejujejo uporabo in posedovanje prepovedanih snovi in postopkov v športu, razen če uporaba temelji na terapevtski izjemi. 3. Noben ukrep, sprejet na podlagi te konvencije, ne preprečuje, da bi bile snovi in postopki, ki so v športu sicer prepovedani ali nadzorovani, dostopni za zakonite namene. Države pogodbenice zoper spremljajoče osebje, ki krši protidopinško pravilo ali stori drugo kaznivo dejanje, povezano z uporabo nedovoljenih snovi v športu, sprejmejo ukrepe, tudi sankcije ali kazni, same ali spodbujajo športne organizacije in protidopinške organizacije, naj sprejmejo take ukrepe. Kadar je primerno, države pogodbenice proizvajalce in prodajalce prehranskih dodatkov spodbujajo k čim boljšemu trženju in prodaji prehranskih dodatkov ter dajejo informacije o njihovi kemijski sestavi in zagotavljanju kakovosti. Kadar je primerno, države pogodbenice: (a) iz svojih proračunov zagotavljajo sredstva za financiranje nacionalnega programa testiranja v vseh športnih panogah ali športnim in protidopinškim organizacijam pomagajo financirati dopinški nadzor z neposrednimi subvencijami ali donacijami ali s priznavanjem stroškov takega nadzora, kadar jim odmerjajo znesek subvencije ali donacije; (b) sprejemajo ukrepe, s katerimi zadržijo s športom povezano finančno pomoč posameznim športnikom ali spremljajočemu osebju, ki začasno ne smejo tekmovati zaradi kršitve protidopinških pravil; (c) delno ali v celoti zadržijo finančno ali drugo s športom povezano pomoč športni organizaciji ali protidopinški organizaciji, ki ne spoštuje kodeksa ali veljavnih protidopinških pravil, sprejetih na podlagi kodeksa. Kadar je primerno, države pogodbenice: (a) spodbujajo športne in protidopinške organizacije, ki so v njihovi pristojnosti, da opravljajo dopinški nadzor skladno s kodeksom, vključno s testiranjem brez vnaprejšnjega obvestila, testiranjem na tekmovanju in zunaj njega, in jim tak nadzor omogočajo; (b) spodbujajo in omogočajo, da športne in protidopinške organizacije sprejmejo sporazume, ki omogočajo, da njihove člane testirajo pooblaščene skupine za dopinški nadzor iz drugih držav; (c) se zavezujejo, da bodo športnim in protidopinškim organizacijam, ki so v njihovi pristojnosti, pomagale pri dostopu do akreditiranega laboratorija za dopinški nadzor, da bo opravil kontrolno analizo. Države pogodbenice spodbujajo sodelovanje med protidopinškimi organizacijami, organi oblasti in športnimi organizacijami, ki so v njihovi pristojnosti, ter organizacijami, ki so v pristojnosti drugih držav, da bodo na mednarodni ravni doseženi nameni te konvencije. Države pogodbenice se zavezujejo, da bodo podpirale pomembno poslanstvo SPA v mednarodnem boju proti uporabi nedovoljenih snovi. Države pogodbenice podpirajo načelo, da organi oblasti in olimpijsko gibanje financirajo odobreni letni osnovni proračun SPA. Ob spoznanju, da je boj proti uporabi nedovoljenih snovi v športu lahko učinkovit le, kadar se športniki lahko testirajo brez vnaprejšnjega obvestila in se vzorci pravočasno pošljejo v laboratorijsko preiskavo, države pogodbenice, kadar je ustrezno in skladno z notranjim pravom in postopki: (a) omogočijo, da SPA in protidopinške organizacije, ki delujejo skladno s kodeksom in upoštevanjem ustreznih predpisov držav gostiteljic, opravljajo dopinški nadzor njihovih športnikov na tekmovanjih ali zunaj njih na njihovem ozemlju ali drugje; (b) omogočajo pravočasno čezmejno gibanje pooblaščenih skupin za dopinški nadzor, ko opravljajo dopinški nadzor; (c) sodelujejo, da pospešijo pravočasno čezmejno pošiljanje ali prevoz vzorcev tako, da zagotavljajo njihovo varnost in celovitost; (d) pomagajo pri mednarodnem usklajevanju dopinškega nadzora, ki ga opravljajo razne protidopinške organizacije, in v ta namen sodelujejo s SPA; (e) spodbujajo sodelovanje med laboratoriji za dopinški nadzor, ki so v njihovi pristojnosti, in laboratoriji, ki so v pristojnosti drugih držav pogodbenic. Države pogodbenice z akreditiranimi laboratoriji za dopinški nadzor morajo predvsem spodbujati laboratorije, ki so v njihovi pristojnosti, da drugim državam pogodbenicam pomagajo pridobiti izkušnje, veščine in tehnologije, potrebne za ustanavljanje njihovih lastnih laboratorijev, če to želijo; (f) spodbujajo in podpirajo dogovore o vzajemnem testiranju med pristojnimi protidopinškimi organizacijami skladno s kodeksom; (g) medsebojno priznavajo postopke za dopinški nadzor in ravnanje z izsledki testiranj, vključno s sankcijami v športu, ki jih v tej zvezi izreče katera koli protidopinška organizacija in so skladne s kodeksom. 1. Ustanovljen je Sklad za odpravo uporabe nedovoljenih snovi v športu, v nadaljevanju sklad prostovoljnih prispevkov. Sklad prostovoljnih prispevkov se sestoji iz sredstev v upravljanju, določenih skladno s finančnimi predpisi Unesca. Vsi prispevki držav pogodbenic in drugih udeležencev so prostovoljni. 2. Sredstva sklada prostovoljnih prispevkov sestavljajo: (a) prispevki držav pogodbenic; (b) prispevki, darila ali zapuščina, ki jih dajo: i) druge države; ii) organizacije in programi Združenih narodov, predvsem Razvojni program Združenih narodov, ter druge mednarodne organizacije; iii) javne ali zasebne ustanove ali posamezniki; (c) obresti na sredstva sklada prostovoljnih prispevkov; (d) sredstva, pridobljena s prostovoljnimi prispevki in prejemki iz prireditev, organiziranih v korist sklada prostovoljnih prispevkov; (e) vsi drugi viri sredstev, dovoljeni s pravilniki sklada prostovoljnih prispevkov, ki jih sprejme konferenca pogodbenic. 3. Upošteva se, da prispevki, ki jih v sklad prostovoljnih prispevkov vplačajo države pogodbenice, niso nadomestilo za obveznost držav pogodbenic, da plačajo svoj delež v letni proračun SPA. Konferenca pogodbenic dodeljuje sredstva iz sklada prostovoljnih prispevkov za financiranje dejavnosti, ki jih sama odobri, predvsem da bi pomagali državam pogodbenicam pri razvijanju in izvajanju protidopinških programov skladno z določbami te konvencije ob upoštevanju ciljev SPA; ta sredstva se lahko uporabljajo za kritje stroškov izvajanja te konvencije. Za prispevke, vplačane v sklad prostovoljnih prispevkov, se ne smejo postavljati politični, ekonomski ali drugi pogoji. 1. Države pogodbenice se zavezujejo, da bodo po svojih možnostih podpirale, razvijale ali izvajale programe izobraževanja in usposabljanja o protidopinških ukrepih. Cilj teh programov je širšo športno skupnost sproti in točno obveščati o: (a) škodi, ki jo uporaba nedovoljenih snovi povzroča etičnim vrednotam športa; (b) posledicah uporabe nedovoljenih snovi za zdravje. 2. Programi izobraževanja in usposabljanja morajo zagotoviti, da so športniki in spremljajoče osebje, predvsem pri začetnem usposabljanju, poleg že navedenega sproti in točno obveščeni o: (a) postopkih dopinškega nadzora; (b) pravicah in obveznostih športnikov v zvezi s protidopinškimi ukrepi, vključno z informacijami o kodeksu in protidopinških politikah ustreznih športnih in protidopinških organizacij. Seznanjeni morajo biti s posledicami kršitve protidopinških pravil; (c) seznamu prepovedanih snovi in postopkov ter terapevtskih izjemah; (d) prehranskih dodatkih. Države pogodbenice spodbujajo pristojna strokovna združenja in ustanove k razvijanju in izvajanju primernih pravil ravnanja, dobre prakse in etike, povezanih z ukrepi proti uporabi nedovoljenih snovi v športu in skladnih s kodeksom. Države pogodbenice spodbujajo in po svojih zmožnostih podpirajo dejavno vključevanje športnikov in spremljajočega osebja v vse oblike protidopinškega dela športnih in drugih ustreznih organizacij in spodbujajo športne organizacije v svoji pristojnosti, da storijo enako. Države pogodbenice spodbujajo športne organizacije in protidopinške organizacije, da stalno izvajajo programe izobraževanja in usposabljanja za športnike in spremljajoče osebje o vsebinah 19. člena. Države pogodbenice sodelujejo med seboj in z ustreznimi organizacijami, da si izmenjavajo, kadar je ustrezno, informacije, strokovno znanje in izkušnje o učinkovitih protidopinških programih. Države pogodbenice se zavezujejo, da bodo po svojih zmožnostih v sodelovanju s športnimi in drugimi ustreznimi organizacijami spodbujale in pospeševale protidopinške raziskave o: (a) postopkih za preprečevanje in odkrivanje uporabe nedovoljenih snovi, vedenjskih in socialnih vidikih take uporabe ter o njenih posledicah za zdravje; (b) načinih in sredstvih za razvijanje znanstveno utemeljenih programov fiziološkega in psihološkega usposabljanja, ki spoštujejo človekovo integriteto; (c) uporabi vseh novih snovi in postopkov, ki so posledica napredka znanosti. Ko spodbujajo protidopinške raziskave iz 24. člena, države pogodbenice zagotavljajo, da te raziskave: (a) spoštujejo mednarodno priznano etično prakso; (b) preprečujejo dajanje prepovedanih snovi in postopkov športnikom; (c) potekajo le s potrebno previdnostjo, da se preprečita zloraba izsledkov protidopinške raziskave in njihova uporaba. Države pogodbenice si ob upoštevanju veljavnega notranjega in mednarodnega prava izmenjavajo izsledke razpoložljivih protidopinških raziskav z drugimi državami pogodbenicami in SPA. Države pogodbenice spodbujajo: (a) člane znanstvenih in medicinskih skupnosti, naj skladno z načeli kodeksa opravljajo raziskave v športni znanosti; (b) športne organizacije in spremljajoče osebje, ki so v njihovi pristojnosti, naj opravljajo raziskave v športni znanosti, skladne z načeli kodeksa. 1. Ustanovi se konferenca pogodbenic. Konferenca pogodbenic je neodvisen organ te konvencije. 2. Konferenca pogodbenic se sestaja na rednih zasedanjih načeloma vsaki dve leti. Konferenca se lahko sestane na izrednem zasedanju, če se tako odloči ali to zahteva vsaj ena tretjina držav pogodbenic. 3. Vsaka država pogodbenica ima na konferenci pogodbenic en glas. 4. Konferenca pogodbenic sprejme svoj poslovnik. SPA je na konferenco pogodbenic vabljena kot svetovalna organizacija. Mednarodni olimpijski komite, Mednarodni paraolimpijski komite, Svet Evrope in Medvladni odbor za športno vzgojo in šport (MOŠVŠ) so vabljeni kot opazovalci. Konferenca pogodbenic se lahko odloči, da kot opazovalce vabi še druge ustrezne organizacije. 1. Poleg nalog iz drugih določb te konvencije so naloge konference pogodbenic, da: (a) podpira namen te konvencije; (b) razpravlja o razmerjih s SPA in preučuje načine financiranja letnega temeljnega proračuna SPA. Države nepogodbenice so lahko vabljene k razpravi; (c) sprejme načrt o uporabi sredstev sklada prostovoljnih prispevkov skladno z 18. členom; (d) pregleduje poročila, ki jih države pogodbenice predložijo skladno z 31. členom; (e) redno pregleduje spremljanje skladnosti s to konvencijo zaradi razvoja protidopinških sistemov v skladu z 31. členom. Sistem ali ukrep nadziranja, ki presega 31. člen, se financira iz sklada prostovoljnih prispevkov v skladu s 17. členom; (f) pregleduje osnutke sprememb te konvencije zaradi njihovega sprejetja; (g) zaradi odobritve skladno s 34. členom konvencije pregleduje spremembe seznama prepovedanih snovi in postopkov 2005 in standardov za priznanje terapevtskih izjem, ki jih sprejme SPA; (h) opredeli in uresničuje sodelovanje med državami pogodbenicami in SPA po tej konvenciji; (i) na vsakem svojem zasedanju zahteva v pregled poročilo SPA o izvajanju kodeksa. 2. Konferenca pogodbenic lahko opravlja svoje naloge v sodelovanju z drugimi medvladnimi organi. Države pogodbenice vsaki dve leti pošljejo konferenci pogodbenic prek sekretariata v enem od uradnih jezikov Unesca vse ustrezne informacije o ukrepih, ki so jih sprejele, da bi ravnale skladno z določbami te konvencije. 1. Tajniške storitve konference pogodbenic zagotavlja generalni direktor Unesca. 2. Na zahtevo konference pogodbenic generalni direktor Unesca v največjem mogočem obsegu uporablja storitve SPA po pogojih, določenih na konferenci pogodbenic. 3. Stroški za izvajanje konvencije se do primernega zneska krijejo iz obstoječih virov rednega proračuna Unesca, iz sklada prostovoljnih prispevkov, kot to določa 17. člen konvencije, ali pa s kombinacijo obeh virov, kar se določi vsaki dve leti. Skretariat se iz rednega proračuna financira v strogo najnižji mogoči višini, pri čemer velja, da bo zagotovljeno tudi financiranje iz prostovoljnih prispevkov. 4. Sekretariat pripravlja dokumentacijo konference pogodbenic ter osnutek dnevnega reda njenih zasedanj in zagotavlja izvajanje njenih sklepov. 1. Vsaka država pogodbenica lahko s pisnim obvestilom, poslanim generalnemu direktorju Unesca, predlaga spremembe te konvencije. Generalni direktor pošlje tako obvestilo v kroženje vsem državam pogodbenicam. Če v šestih mesecih po datumu, ko je bilo obvestilo poslano v kroženje, vsaj polovica držav pogodbenic izrazi svoje soglasje k predlogu sprememb, generalni direktor take predloge predstavi na naslednjem zasedanju konference pogodbenic. 2. Konferenca pogodbenic sprejema spremembe z dvotretjinsko večino navzočih držav pogodbenic, ki glasujejo. 3. Ko so spremembe te konvencije sprejete, se državam pogodbenicam predložijo v ratifikacijo, sprejetje, odobritev ali pristop. 4. Za države pogodbenice, ki so jih ratificirale, sprejele, odobrile ali pristopile k njim, spremembe te konvencije začnejo veljati po treh mesecih, ko sta dve tretjini držav pogodbenic deponirali listine iz tretjega odstavka tega člena. Nato začne za vsako državo pogodbenico, ki spremembo ratificira, sprejme, odobri ali k njej pristopi, navedena sprememba veljati tri mesece po datumu, ko je država pogodbenica deponirala svojo listino o ratifikaciji, sprejetju, odobritvi ali pristopu. 5. Država, ki skladno s četrtim odstavkom tega člena postane pogodbenica te konvencije po začetku veljavnosti sprememb, se, če ne izrazi drugačne namere, šteje za: (a) pogodbenico tako spremenjene konvencije; (b) pogodbenico nespremenjene konvencije, če gre za katero koli državo pogodbenico, ki je spremembe ne zavezujejo. 1. Če SPA spremeni seznam prepovedanih snovi in postopkov 2005 ali standarde za priznanje terapevtskih izjem, lahko s temi spremembami s pisnim obvestilom seznani generalnega direktorja Unesca. Generalni direktor vse države pogodbenice nemudoma uradno obvesti o teh spremembah kot o predlaganih spremembah prilog k tej konvenciji. Spremembe prilog odobri konferenca pogodbenic na enem od svojih zasedanj ali s pisnim posvetovanjem. 2. Države pogodbenice lahko v 45 dneh od uradnega obvestila generalnega direktorja izrazijo svoj ugovor na predlagano spremembo v pisni obliki generalnemu direktorju, če gre za pisno posvetovanje, ali na zasedanju konference pogodbenic. Če dve tretjini držav pogodbenic ne izrazita svojega ugovora, se šteje, da je predlagano spremembo odobrila konferenca pogodbenic. 3. Generalni direktor uradno obvesti države pogodbenice o spremembah, ki jih je odobrila konferenca pogodbenic. Spremembe začnejo veljati 45 dni po tem uradnem obvestilu, razen če je država pogodbenica generalnega direktorja predhodno obvestila, da ne sprejema teh sprememb. 4. Državo pogodbenico, ki je generalnega direktorja uradno obvestila o tem, da ne sprejema spremembe, odobrene skladno s prejšnjimi odstavki, še naprej zavezujejo nespremenjene priloge. Za države pogodbenice, ki imajo zvezno ali necentralizirano ustavno ureditev, se uporabljajo te določbe: (a) za določbe te konvencije, katerih izvajanje je v sodni pristojnosti zvezne ali centralne zakonodajne oblasti, so obveznosti zvezne ali centralne vlade enake, kot so obveznosti držav pogodbenic, ki niso zvezne države; (b) za določbe te konvencije, katerih izvajanje je v sodni pristojnosti posameznih držav, dežel ali kantonov v sestavi, ki jih ustavni sistem federacije ne zavezuje, da morajo sprejemati zakonodajne ukrepe, zvezna vlada pristojne organe takih držav, dežel ali kantonov obvesti o omenjenih določbah in jim priporoči, da jih sprejmejo. Konvencijo morajo države članice Unesca ratificirati, sprejeti, odobriti ali k njej pristopiti skladno s svojimi notranjepravnimi postopki. Listine o ratifikaciji, sprejetju, odobritvi ali pristopu se deponirajo pri generalnem direktorju Unesca. 1. Ta konvencija začne veljati prvi dan meseca po poteku enega meseca po deponiranju tridesete listine o ratifikaciji, sprejetju, odobritvi ali pristopu. 2. Za vsako državo, ki pozneje izrazi svoje soglasje k temu, da jo ta konvencija zavezuje, začne konvencija veljati prvi dan meseca po poteku enega meseca po deponiranju njene listine o ratifikaciji, sprejetju, odobritvi ali pristopu. 1. Vsaka država lahko ob deponiranju svoje listine o ratifikaciji, sprejetju, odobritvi ali pristopu določi ozemlje ali ozemlja, na katerih je pristojna za mednarodne odnose in za katera se ta konvencija uporablja. 2. Država pogodbenica lahko kadar koli pozneje z izjavo, ki jo pošlje Unescu, razširi uporabo te konvencije na katero koli drugo ozemlje, določeno v izjavi. Za tako ozemlje začne konvencija veljati prvi dan po poteku enega meseca po datumu, ko depozitar prejme tako izjavo. 3. Izjavo, dano po obeh prejšnjih odstavkih, je v zvezi s katerim koli ozemljem, navedenim v taki izjavi, mogoče umakniti z uradnim obvestilom, poslanim Unescu. Tak umik začne veljati prvi dan po poteku enega meseca po datumu, ko depozitar prejme tako uradno obvestilo. Vsaka država pogodbenica lahko odpove to konvencijo. Odpoved je uradno sporočena z listino, deponirano pri generalnem direktorju Unesca. Odpoved začne veljati prvi dan meseca po poteku šestih mesecev po prejemu listine o odpovedi. Odpoved v nobenem primeru ne vpliva na finančne obveznosti države pogodbenice, nastale do datuma, ko je odpoved začela veljati. Generalni direktor Unesca je depozitar te konvencije in sprememb k njej. Generalni direktor Unesca kot depozitar obvesti države pogodbenice te konvencije ter druge države članice organizacije o: (a) deponiranju vsake listine o ratifikaciji, sprejetju, odobritvi ali pristopu; (b) datumu začetka veljavnosti te konvencije skladno s 37. členom; (c) vsakem poročilu, pripravljenem na podlagi 31. člena; (d) vsaki spremembi konvencije ali prilog, sprejetih skladno s 33. in 34. členom, in datumu, ko začne sprememba veljati; (e) vsaki izjavi ali uradnem obvestilu, poslanem po 38. členu; (f) vsakem uradnem obvestilu, poslanem po 39. členu, in datumu, ko odpoved začne veljati; (g) vsakem drugem aktu, uradnem obvestilu ali sporočilu v zvezi s to konvencijo. Skladno s 102. členom Listine Združenih narodov se ta konvencija vpiše v register pri Sekretariatu Združenih narodov na zahtevo generalnega direktorja Unesca. 1. Ta konvencija in njene priloge so v angleškem, arabskem, francoskem, kitajskem, ruskem in španskem jeziku, pri čemer so vsa besedila enako verodostojna. 2. Dodatki k tej konvenciji so v angleškem, arabskem, francoskem, kitajskem, ruskem in španskem jeziku. Pridržki, ki niso združljivi z vsebino in namenom te konvencije, niso dopustni. Sestavljeno v Parizu osemnajstega novembra 2005 v dveh verodostojnih izvodih, ki sta ju na 33. zasedanju podpisala predsednik Generalne konference Unesca in generalni direktor Unesca in se deponirata v arhivu Unesca. Prilogi 1. Seznam prepovedanih snovi in postopkov – mednarodni standard 2. Standardi za priznanje terapevtskih izjem Dodatki 1. Svetovni kodeks proti dopingu 2. Mednarodni standard za laboratorije 3. Mednarodni standard za testiranje Za uradno besedilo seznama prepovedanih snovi in postopkov skrbi WADA, objavljeno pa je v angleškem in francoskem jeziku. Če se pojavi neskladje med različico v angleškem in francoskem jeziku, prevlada različica v angleškem jeziku. Uporaba katerega koli zdravila mora biti omejena na medicinsko utemeljene indikacije. S1. ANABOLIČNI DEJAVNIKI Anabolični dejavniki so prepovedani. 1. Anabolični androgeni steroidi (AAS) a) Eksogeni* AAS, vključno z navedenimi: 18alfa-homo-17beta-hidroksiester-4-en-3-on, bolasteron, boldenon, boldion, kalusteron, klostebol, danazol, dehidroklorometiltestosteron, delta1-androsten-3,17-dion, delta1-androstenediol, delta1-dihidro-testosteron, drostanolon, etilestrenol, fluoksimesteron, formebolon, furazabol, gestrinon, 4-hidroksitestosteron, 4-hidroksi-19-nortestosteron, mestanolon, mesterolon, metenolon, metandienon, metandriol, metildienolon, metiltrienolon, metiltestosteron, miboleron, nandrolon, 19-norandrostenediol; 19-norandrostenedion, norboleton, norklostebol, noretandrolon, oksabolon, oksandrolon, oksimesteron, oksimetolon, quinbolon, stanozolol, stenbolon, tetrahidrogestrinon, trenbolon in druge snovi s podobno kemijsko strukturo ali podobnim biološkim učinkom ali učinki. b) Endogeni** AAS: androstenediol (androst-5-en-3beta,17beta-diol), androstenedion (androst-4- en-3,17-dion), dehidroepiandrosteron (DHEA), dihidrotestosteron, testosteron ter naslednji presnovki in izomeri: 5alfa-androstan-3alfa, 17alfa-diol, 5alfa-androstan-3alfa,17beta-diol, 5alfa-androstan-3beta,17alfa-diol, 5alfa-androstan-3beta,17beta-diol, androst-4-ene-3alfa,17alfa-diol, androst-4-en-3alfa,17beta-diol, androst-4-en-3beta,17alfa-diol, androst-5-en-3alfa,17alfa-diol, androst-5-en-3alfa,17beta-diol, androst-5-en-3beta,17alfa-diol, 4-androstenediol (androst-4-en-3beta,17beta-diol), 5-androstenedion (androst-5-en-3,17-dion), epi-dihidrotestosteron, 3alfa-hidroksi-5alfa-androstan-17-on, 3beta-hidroksi-5alfa-androstan-17-on, 19-norandrosteron, 19-noretioholanolon. Kadar je prepovedana snov (navedena zgoraj) lahko tudi naravni proizvod telesa, se šteje, da vzorec vsebuje tako prepovedano snov, kadar koncentracija prepovedane snovi ali presnovka oziroma označevalca in/ali katero koli drugo razmerje ali razmerja takih snovi v športnikovem vzorcu toliko odstopajo od vrednosti, ki se po navadi najdejo pri ljudeh, da ne morejo normalno endogeno nastati. Šteje se, da vzorec ne vsebuje prepovedane snovi, če športnik dokaže, da sta lahko koncentracija prepovedane snovi ali presnovka oziroma označevalca in/ali katero koli drugo razmerje takih snovi v športnikovem vzorcu posledica fiziološkega ali patološkega stanja. Laboratorij v vsakem primeru in pri vsaki koncentraciji sporoči pozitivni laboratorijski rezultat, če lahko na podlagi zanesljive analitične metode dokaže, da je prepovedana snov eksogenega izvora. Če laboratorijski rezultat ni dokončen in ni odkrita nobena koncentracija iz prejšnjega odstavka, ustrezna protidopinška organizacija, če obstajajo zanesljivi znaki, opravi nadaljnje preiskave, kot je primerjava referenčnih steroidnih profilov, da tako ugotovi morebitno uporabo prepovedane snovi. Če laboratorij sporoči razmerje T/E v urinu, večje od štiri

(4)proti ena (1), so nadaljnje preiskave obvezne, zato da se ugotovi, ali je razmerje posledica fiziološkega ali patološkega stanja, razen če laboratorij sporoči pozitivni laboratorijski rezultat, ki z zanesljivo analitično metodo dokazuje, da je prepovedana snov eksogenega izvora. Če se opravi preiskava, ta vsebuje pregled morebitnih prejšnjih in/ali poznejših testov. Če prejšnji testi niso na voljo, je športnik nenapovedano testiran najmanj trikrat v obdobju treh mesecev. Če športnik odkloni sodelovanje v preiskavah, se šteje, da njegov vzorec vsebuje prepovedano snov. 2. Drugi anabolični dejavniki so med drugim: klenbuterol, zeranol, zilpaterol. V tem razdelku: * »eksogeni« pomeni snov, ki je telo ni sposobno proizvajati po naravni poti; ** »endogeni« pomeni snov, ki jo je telo sposobno proizvajati po naravni poti. S2. HORMONI IN SORODNE SNOVI Naslednje snovi, vključno z drugimi snovmi s podobno kemijsko strukturo ali podobnim biološkim učinkom ali učinki, in njihovi sproščajoči dejavniki so prepovedani: 1. eritropoetin (EPO), 2. rastni hormon (hGH), inzulinu podobni rastni dejavnik (IGF-1), mehanorastni dejavniki (MGF), 3. gonadotropini (LH, hCG), 4. inzulin, 5. kortikotropini. Če športniku ne uspe dokazati, da je bila koncentracija posledica fiziološkega ali patološkega stanja, se šteje, da vzorec vsebuje prepovedano snov (navedeno zgoraj), kadar koncentracija prepovedane snovi ali presnovka in/ali ustreznih razmerij ali označevalcev v športnikovem vzorcu toliko presega vrednosti, ki se po navadi najdejo pri ljudeh, da ne morejo normalno endogeno nastati. Prisotnost drugih snovi s podobno kemijsko strukturo ali podobnim biološkim učinkom ali učinki, prisotnost diagnostičnih označevalcev ali sproščajočih dejavnikov hormona, navedenih zgoraj, ali kak drug rezultat, ki kaže, da je odkrita snov eksogenega izvora, se sporoči kot pozitivni laboratorijski rezultat. S3. AGONISTI BETA-2 Vsi agonisti beta-2 skupaj z D- in L-izomeri so prepovedani. Za njihovo uporabo se zahteva priznanje terapevtske izjeme. Za uporabo formoterola, salbutamola, salmeterola in terbutalina v obliki inhalatorjev za preprečevanje in/ali zdravljenje astme in s fizično dejavnostjo povzročene astme/bronhospazma se izjemoma zahteva priznanje terapevtske izjeme po skrajšanem postopku. Kljub priznanju terapevtske izjeme pa se vsaka koncentracija salbutamola (prosti in glukuronid), višja od 1000 ng/ml, ki jo sporoči laboratorij, šteje za pozitivni rezultat, če športnik ne dokaže, da je nenormalni rezultat posledica terapevtske uporabe inhaliranega salbutamola. S4. DEJAVNIKI Z ANTIESTROGENSKIM DELOVANJEM Prepovedani so naslednji razredi snovi z antiestrogenskim delovanjem: 1. aromatizirani inhibitorji, kot so med drugim anastrozol, letrozol, aminoglutetimid, eksemestan, formestan, testolakton; 2. selektivni modulatorji estrogenskih receptorjev (SERM), kot so med drugim raloksifen, tamoksifen, toremifen; 3. druge antiestrogenske snovi, kot so med drugim klomifen, ciklofenil, fulvestrant. S5. DIURETIKI IN DRUGI MASKIRNI DEJAVNIKI Diuretiki in drugi maskirni dejavniki so prepovedani. Maskirni dejavniki so med drugim: diuretiki*, epitestosteron, probenecid, alfa-reduktazni inhibitorji (npr. finasterid, dutasterid), ekspanderji plazme (npr. albumin, dekstran, hidroksietil škrob). Diuretiki so: acetazolamid, amilorid, bumetanid, kanrenon, klortalidon, etakrinska kislina, furosemid, indapamid metolazon, spironolakton, tiazidi (npr. bendroflumetiazid, klorotiazid, hidroklorotiazid), triamteren in druge snovi s podobno kemijsko strukturo ali podobnim biološkim učinkom ali učinki. * Terapevtska izjema ne velja, če športnikov urin vsebuje diuretik hkrati z največ mejno koncentracijo katere koli prepovedane snovi. M1. POVEČANJE PRENOSA KISIKA Prepovedano je naslednje: a) krvni doping, vključno z uporabo avtologne, homologne ali heterologne krvi ali eritrocitnih proizvodov kakršnega koli izvora, razen za zdravljenje; b) umetno povečanje vnosa, prenosa ali oskrbe s kisikom, kot so med drugim perfluorokemične snovi, efaproksiral (RSR13) in modificirani hemoglobinski proizvodi (npr. krvni nadomestki na osnovi hemoglobina, mikroinkapsulirani hemoglobinski proizvodi). M2. KEMIČNO IN FIZIČNO POTVARJANJE Prepovedano je naslednje: ponarejanje ali poskus ponarejanja, da bi se spremenili integriteta in veljavnost vzorcev, odvzetih v dopinških kontrolah. To med drugim vključuje intravenozne infuzije*, kateterizacijo in zamenjavo urina. * Razen za nujno potrebno zdravljenje akutnih stanj so intravenozne infuzije prepovedane. M3. GENSKI DOPING Neterapevtska uporaba celic, genov, genskih elementov ali modulacija genske ekspresije, ki lahko vpliva na športni dosežek, je prepovedana. S6. POŽIVILA Prepovedana so naslednja poživila, vključno z obema optičnima izomeroma (D- in L-), kadar je to pomembno: adrafinil, amfepramone, amifenazol, amfetamin, amfetaminil, benzfetamin, bromantan, karfedon, katin*, klobenzoreks, kokain, dimetilamfetamin, efedrin**, etilamfetamin, etilefrin, famprofazon, fencamfamin, fencamin, fenetilin, fenfluramin, fenproporeks, furfenoreks, mefenoreks, mefentermin, mesocarb, metamfetamin, metilamfetamin, metilenedioksiamfetamin, metilenedioksimetamfetamin, metilefedrin**, metilfenidat, modafinil, niketamid, norfenfluramin, parahidroksiamfetamin, pemolin, fendimetrazin, fenmetrazin, fentermin, prolintan, selegilin, strihnin in druge snovi s podobno kemijsko strukturo ali podobnim biološkim učinkom ali učinki***. * Katin je prepovedan, kadar njegova koncentracija v urinu presega 5 mikrogramov na mililiter. ** Efedrin in metilefedrin sta prepovedana, kadar njuna koncentracija presega 10 mikrogramov na mililiter. *** Snovi, ki so vključene v Program nadzora 2005 (bupropion, kofein, fenilefrin, fenilpropanolamin, pipradrol, psevdoefedrin, sinefrin), niso obravnavane kot prepovedane snovi. OPOMBA: Adrenalin v kombinaciji z lokalnimi anestetiki ali lokalno uporabo (npr. nazalna, oftalmološka) ni prepovedan. S7. NARKOTIKI Prepovedani so naslednji narkotiki: buprenorfin, dekstromoramid, diamorfin (heroin), fentanil in njegovi derivati, hidromorfon, metadon, morfin, oksikodon, oksimorfon, pentazocin, petidin. S8. KANABINOIDI Kanabinoidi (npr. hašiš, marihuana) so prepovedani. S9. GLUKOKORTIKOSTEROIDI Vsi glukokortikosteroidi so prepovedani, kadar se uporabljajo oralno, rektalno, intravenozno ali intramuskularno. Za njihovo uporabo se zahteva priznanje terapevtske izjeme. Pri vseh drugih načinih uporabe se zahteva priznanje terapevtske izjeme po skrajšanem postopku. Dermatološki preparati niso prepovedani. P1. ALKOHOL Alkohol (etanol) je prepovedan samo na tekmovanju v naslednjih športih. Odkrivanje se opravi z analizo izdihanega zraka in/ali krvi. Mejna vrednost kršitve je pri posameznih zvezah navedena v oklepaju: – letalstvo (FAI) (0,20 g/l), – lokostrelstvo (FITA) (0,10 g/l), – avtomobilizem (FIA) (0,10 g/l), – biljard (WCBS) (0,20 g/l), – balinanje (CMSB) (0,10 g/l), – karate (WKF) (0,10 g/l), – moderni peteroboj (UIPM) (0,10 g/l), za discipline, ki vključujejo streljanje – motociklizem (FIM) (0,00 g/l) – smučanje (FIS) (0,10 g/l). P2. BLOKATORJI BETA Če ni drugače določeno, so blokatorji beta prepovedani samo na tekmovanju v naslednjih športih: – letalstvo (FAI), – lokostrelstvo (FITA) (prepovedani tudi zunaj tekmovanja), – avtomobilizem (FIA), – biljard (WCBS), – bob (FIBT), – balinanje (CMSB), – bridž (FMB), – šah (FIDE), – kegljanje na ledu (WCF), – gimnastika (FIG), – motociklizem (FIM), – moderni peteroboj (UIPM), za discipline, ki vključujejo streljanje, – kegljanje (FIQ), – jadranje (ISAF), samo za krmarje v jadralnih dvobojih, – streljanje (ISSF) (prepovedano tudi zunaj tekmovanja), – smučanje (FIS) pri smučarskih skokih in deskanju na snegu v prostem slogu, – plavanje (FINA) pri skokih v vodo in sinhronem plavanju, – rokoborba (FILA). Blokatorji beta so med drugim naslednji: acebutolol, alprenolol, atenolol, betaksolol, bisoprolol, bunolol, karteolol, karvedilol, celiprolol, esmolol, labetalol, levobunolol, metipranolol, metoprolol, nadolol, oksprenolol, pindolol, propranolol, sotalol, timolol. »Specificirane snovi«* so navedene spodaj: – efedrin, L-metilamfetamin, metilefedrin, – kanabinoidi, – vsi inhalacijski agonisti beta-2 razen klenbuterola, – probenecid, – vsi glukokortikosteroidi, – vsi blokatorji beta, – alkohol. * »Na Seznamu prepovedanih snovi in postopkov 2005 so lahko navedene specificirane snovi, s katerimi se zaradi njihove splošne dostopnosti v zdravilih še zlasti lahko nenamerno kršijo protidopinška pravila ali za katere je malo verjetno, da bi se uspešno zlorabile za doping.« Kršitev protidopinških pravil s takimi snovmi ima lahko za posledico blažje sankcije, če »… športnik lahko dokaže, da uporaba take specificirane snovi ni bila namenjena izboljšanju športnega dosežka …«. 4.0 Merila za priznanje terapevtske izjeme Športniku se lahko prizna terapevtska izjema, s katero se dovoljuje uporaba prepovedanih snovi ali postopkov, navedenih na seznamu prepovedanih snovi in postopkov. Vlogo za terapevtsko izjemo pregleda odbor za priznanje terapevtske izjeme (OPTI). OPTI imenuje protidopinška organizacija. Izjema se prizna izključno v skladu z naslednjimi merili: [Opomba: Ta standard velja za vse športnike, kot je opredeljeno v kodeksu in v skladu z njim, tj. za športnike in športnike invalide. Uporablja se glede na okoliščine posameznika. Na primer, izjema, ki je primerna za športnike invalide, je lahko neprimerna za druge športnike.] 4.1 Športnik mora vlogo za terapevtsko izjemo vložiti najmanj 21 dni pred udeležbo na športnem dogodku. 4.2 Za športnika bi prekinitev terapije s prepovedano snovjo ali postopkom med zdravljenjem akutnega ali kroničnega zdravstvenega stanja pomenila hujše poslabšanje zdravja. 4.3 Terapevtska uporaba prepovedane snovi ali postopka ne bi omogočila dodatnega izboljšanja športnega dosežka razen tistega, ki ga je mogoče pričakovati zaradi izboljšanja zdravstvenega stanja po zdravljenju potrjenega bolezenskega stanja. Uporaba katere koli prepovedane snovi ali postopka, zato da bi se zvišala »nizka normalna« raven endogenega hormona, se ne šteje za dopusten terapevtski poseg. 4.4 Za uporabo sicer prepovedane snovi ali postopka ni nobene druge utemeljene terapevtske možnosti. 4.5 Potreba, da se uporabi sicer prepovedana snov ali postopek, ne more ne deloma ne v celoti izhajati iz predhodne neterapevtske uporabe katere koli snovi s seznama prepovedanih snovi in postopkov. 4.6 Organ, ki prizna terapevtsko izjemo, jo prekliče, če: a) športnik takoj ne izpolni morebitnih zahtev ali pogojev, ki jih nalaga protidopinška organizacija, ki prizna izjemo; b) je rok, za katerega je bila terapevtska izjema priznana, potekel; c) je športnik obveščen, da je protidopinška organizacija preklicala priznanje terapevtske izjeme. [Opomba: Vsaka terapevtska izjema velja določen čas, ki ga določi OPTI. Lahko se zgodi, da je po preteku ali preklicu terapevtske izjeme prepovedana snov, za katero je veljala terapevtska izjema, še vedno v športnikovem telesu. V takih primerih protidopinška organizacija, ki opravi začetni pregled pozitivnega rezultata testa, ugotovi, ali je rezultat skladen s pretekom roka ali preklicem priznane terapevtske izjeme.] 4.7 Vloga za priznanje terapevtske izjeme za nazaj se ne upošteva, razen kadar: (a) je bilo potrebno nujno zdravljenje ali zdravljenje akutnega zdravstvenega stanja ali (b) zaradi izjemnih okoliščin ni bilo dovolj časa ali možnosti, da bi vlagatelj vložil ali OPTI obravnaval vlogo pred dopinško kontrolo. [Opomba: Nujni zdravstveni primeri ali akutna zdravstvena stanja, ki zahtevajo uporabo sicer prepovedane snovi ali postopka, preden je mogoče dati vlogo za priznanje terapevtske izjeme, so redki. Prav tako se ne zgodi pogosto, da bi bilo treba vlogo za priznanje terapevtske izjeme hitro obravnavati zaradi bližajočega se tekmovanja. Protidopinške organizacije, ki priznavajo terapevtske izjeme, morajo imeti notranje postopke, ki omogočajo reševanje takih primerov.] 5.0 Zaupnost podatkov 5.1 Vlagatelj mora dati pisno soglasje, da se vsi podatki iz vloge predložijo članom OPTI in po potrebi drugim neodvisnim zdravstvenim strokovnjakom ali znanstvenikom ali vsemu osebju, ki sodeluje pri vodenju, reviziji ali pritožbi v zvezi s priznanjem terapevtske izjeme. Če je potrebna pomoč zunanjih neodvisnih strokovnjakov, se vsi podatki iz vloge zagotovijo brez navedbe imena in priimka obravnavanega športnika. Vlagatelj mora dati tudi pisno soglasje, da se sklepi OPTI razdelijo drugim vpletenim protidopinškim organizacijam v skladu z določbami kodeksa. 5.2 Člani OPTI in uprava protidopinške organizacije, ki obravnavajo primer, opravljajo vse dejavnosti strogo zaupno. Vsi člani OPTI in vse sodelujoče osebje podpišejo izjavo o varovanju zaupnih podatkov. Zlasti ohranjajo zaupnost naslednjih podatkov: a) vseh zdravstvenih podatkov, ki jih predložijo športnik in zdravnik ali zdravniki, ki so vključeni v oskrbo športnika; b) vseh podatkov, navedenih v vlogi, vključno z imenom in priimkom zdravnika ali zdravnikov, ki pri tem sodelujejo. Če želi športnik preklicati pravico OPTI ali Odbora za priznanje terapevtske izjeme pri WADA, da pridobi njegove zdravstvene podatke, mora o tem pisno obvestiti svojega zdravnika. Posledica take odločitve je, da se športniku ne prizna terapevtska izjema ali njeno podaljšanje. 6.0 Odbori za priznanje terapevtske izjeme (OPTI) OPTI se ustanovijo in delujejo v skladu z naslednjimi smernicami: 6.1 V OPTI morajo sodelovati najmanj trije zdravniki z izkušnjami na področju oskrbe in zdravljenja športnikov ter z dobrim poznavanjem klinične medicine in medicine športa. Da bi zagotovili neodvisno sprejemanje odločitev, večina članov OPTI ne bi smela imeti nobenih uradnih dolžnosti v protidopinški organizaciji. Vsi člani OPTI podpišejo izjavo o izogibanju nasprotja interesov. Pri vlogah, ki se nanašajo na športnike invalide, mora imeti najmanj en član odbora OPTI posebne izkušnje pri oskrbi in zdravljenju športnikov invalidov. 6.2 OPTI lahko poiščejo kakršno koli medicinsko ali znanstveno mnenje strokovnjaka, ki je po njihovem mnenju potrebno pri pregledovanju okoliščin katere koli vloge za priznanje terapevtske izjeme. 6.3 Odbor za priznanje terapevtske izjeme pri WADA je sestavljen na podlagi meril, določenih v 6.1. Odbor za priznanje terapevtske izjeme pri WADA je ustanovljen, da na lastno pobudo pregleda priznanja terapevtskih izjem, ki so jih priznale protidopinške organizacije. Kot je določeno v četrtem odstavku 4. člena kodeksa, Odbor za priznanje terapevtske izjeme pri WADA na prošnjo športnikov, ki jim protidopinška organizacija ni priznala terapevtske izjeme, pregleda take odločitve in jih ima pravico razveljaviti. 7.0 Vloga za priznanje terapevtske izjeme Postopek 7.1 Terapevtska izjema se obravnava le po prejemu izpolnjenega obrazca, ki mu je treba priložiti vse ustrezne dokumente (glej dodatek 1 – obrazec za priznanje terapevtske izjeme). Postopek reševanja vloge mora dosledno potekati v skladu z načeli stroge zaupnosti zdravstvenih podatkov. 7.2 Obrazec ali obrazce za priznanje terapevtske izjeme, določene v dodatku 1, lahko protidopinške organizacije spremenijo, tako da vključijo dodatne zahteve po podatkih, ne smejo pa izpustiti nobenega dela ali točke. 7.3 Protidopinške organizacije lahko obrazec ali obrazce za priznanje terapevtske izjeme prevedejo v drug jezik ali jezike, vendar pa mora na obrazcu ostati tudi besedilo v angleškem ali francoskem jeziku. 7.4 Športnik lahko vloži vlogo za priznanje terapevtske izjeme le pri eni protidopinški organizaciji. V vlogi je treba navesti športnikovo panogo, ter če je potrebno, disciplino in poseben položaj ali vlogo. 7.5 V vlogi je treba navesti morebitne prejšnje in/ali sedanje prošnje, da se dovoli uporaba sicer prepovedane snovi ali postopka, organ, na katerega je bila prošnja naslovljena, in njegovo odločitev. 7.6 Vlagatelj mora predložiti celovito zdravstveno anamnezo in rezultate pregledov, laboratorijskih preiskav in slikanj, ki se nanašajo na vlogo. 7.7 Morebitne dodatne preiskave, pregledi ali slikanja, ki jih zahteva odbor OPTI ali protidopinška organizacija, se opravijo na stroške vlagatelja ali njegove nacionalne športne zveze. 7.8 Vloga mora vsebovati izjavo ustrezno usposobljenega zdravnika, ki potrjuje potrebo po uporabi sicer prepovedane snovi ali postopka pri zdravljenju športnika ter opisuje, zakaj pri zdravljenju tega stanja ni mogoče ali ne bi bilo mogoče uporabiti nadomestnega dovoljenega zdravila. 7.9 Navesti je treba odmerek, pogostost, način in trajanje uporabe sicer prepovedane snovi ali postopka. 7.10 Odločitve mora OPTI sprejeti v 30 dneh od prejema celotne dokumentacije, ustrezna protidopinška organizacija pa z njimi pisno seznani športnika. Kadar se terapevtska izjema prizna športniku, vključenemu v skupino športnikov za nenapovedane dopinške kontrole, se temu športniku in WADA takoj pošlje odobritev, ki vsebuje podatke o trajanju izjeme in pogojih, povezanih s priznanjem terapevtske izjeme. 7.11 (a) Ob prejemu športnikove prošnje v pregled, kot je določeno v četrtem odstavku 4. člena kodeksa, lahko Odbor za priznanje terapevtske izjeme pri WADA, kot je določeno v četrtem odstavku 4. člena kodeksa, razveljavi odločitev o priznanju terapevtske izjeme, ki jo je priznala protidopinška organizacija. Športnik pošlje Odboru za priznanje terapevtske izjeme pri WADA vse podatke za priznanje terapevtske izjeme, ki jih je prvotno predložil protidopinški organizaciji, skupaj s pristojbino za vlogo. Dokler pregled ni končan, velja prvotna odločitev. Postopek ne sme trajati več kot 30 dni od dneva, ko WADA prejme podatke. (b) WADA lahko začne pregled kadar koli. Odbor za priznanje terapevtske izjeme pri WADA konča pregled v 30 dneh. 7.12 Če je odločitev o priznanju terapevtske izjeme po pregledu razveljavljena, ta razveljavitev ne velja za nazaj in ne razveljavi športnikovih dosežkov v obdobju, v katerem je bila terapevtska izjema priznana, in začne veljati najpozneje 14 dni po tem, ko je športnik uradno obveščen o odločitvi. 8.0 Vloga za priznanje terapevtske izjeme Skrajšani postopek 8.1 Priznava se, da se nekatere snovi, navedene na seznamu prepovedanih snovi in postopkov, uporabljajo za zdravljenje zdravstvenih stanj, ki so med športniki pogosta. V takih primerih vloga iz 4. in 7. razdelka ni potrebna. Zato je uveden skrajšani postopek za priznanje terapevtske izjeme. 8.2 Prepovedane snovi ali postopki, ki se s tem skrajšanim postopkom lahko dovolijo, so strogo omejeni na naslednje: agonisti beta-2 (formoterol, salbutamol, salmeterol in terbutalin) z inhalacijo in glukokortikosteroidi z nesistemsko uporabo. 8.3 Za uporabo ene od navedenih snovi športnik pošlje protidopinški organizaciji zdravniško mnenje, ki utemeljuje potrebo po zdravljenju. Tako zdravniško mnenje iz dodatka 2 navaja diagnozo, ime zdravila, odmerek, način uporabe in trajanje zdravljenja. Če je primerno, so navedene tudi vse preiskave, opravljene za postavitev diagnoze (brez dejanskih rezultatov ali podrobnih podatkov). 8.4 Skrajšani postopek poteka na naslednji način: (a) Odobritev uporabe prepovedanih snovi po skrajšanem postopku začne veljati, ko protidopinška organizacija prejme popolno vlogo. Nepopolno vlogo je treba vrniti vlagatelju. (b) Ko protidopinška organizacija prejme popolno vlogo, o tem takoj obvesti športnika. Po potrebi so takoj obveščene tudi mednarodna zveza, nacionalna zveza športnika in nacionalna protidopinška organizacija. Protidopinška organizacija obvesti WADA samo, ko prejme vlogo športnika mednarodnega razreda. (c) Vloga za priznanje terapevtske izjeme po skrajšanem postopku se ne upošteva za nazaj, razen: – če je bilo potrebno nujno zdravljenje ali zdravljenje akutnega zdravstvenega stanja ali – če zaradi izjemnih okoliščin ni bilo dovolj časa ali možnosti, da bi vlagatelj vložil ali OPTI prejel vlogo pred dopinško kontrolo. 8.5 a) OPTI ali Odbor za priznanje terapevtske izjeme pri WADA lahko revizijo sprožita kadar koli med trajanjem veljavnosti terapevtske izjeme po skrajšanem postopku. b) Če športnik zahteva revizijo naslednje zavrnitve priznanja terapevtske izjeme po skrajšanem postopku, lahko Odbor za priznanje terapevtske izjeme pri WADA od športnika zahteva dodatne zdravstvene podatke, če meni, da so potrebni, stroške pa mora plačati športnik. 8.6 OPTI ali Odbor za priznanje terapevtske izjeme pri WADA lahko priznanje terapevtske izjeme po skrajšanem postopku kadar koli prekliče. Športnik, njegova mednarodna zveza in vse ustrezne protidopinške organizacije so o tem takoj uradno obveščene. 8.7 Preklic začne veljati takoj po tem, ko je športnik uradno obveščen o odločitvi. Športnik lahko kljub temu zaprosi za priznanje terapevtske izjeme po razdelku 7. 9.0 Pošiljanje informacij 9.1 Protidopinške organizacije morajo WADA poslati vse priznane terapevtske izjeme in vsa dokazila, izdana v skladu z razdelkom 7. 9.2 V zvezi s priznanjem terapevtske izjeme po skrajšanem postopku iz razdelka 8.4 morajo protidopinške organizacije WADA poslati zdravstvene vloge, ki so jih predložili športniki mednarodnega razreda. 9.3 Pri pošiljanju informacij je dosledno zagotovljena zaupnost vseh zdravstvenih podatkov. Podpisniki